# EDGAR Filing Document

**Accession Number:** 0000945908
**File Stem:** 0001752724-25-154395
**Filing Date:** 2025-6
**Character Count:** 193164
**Document Hash:** 448128f6500962601a58a4513a4ef7ea
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-25-154395.hdr.sgml**: 20250625

**ACCESSION NUMBER**: 0001752724-25-154395

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250430

**FILED AS OF DATE**: 20250625

**DATE AS OF CHANGE**: 20250625

**PERIOD START**: 20250731

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** FIDELITY COVINGTON TRUST
- **CENTRAL INDEX KEY:** 0000945908

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-07319
- **FILM NUMBER:** 251071281

**BUSINESS ADDRESS:**
- **STREET 1:** 245 SUMMER STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210
- **BUSINESS PHONE:** 617-563-7000

**MAIL ADDRESS:**
- **STREET 1:** 245 SUMMER STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210

## Series and Classes Contracts Data

### Fidelity MSCI Health Care Index ETF (Series ID: S000042575)

| Class ID   | Class Name                          | Ticker Symbol   |
|:---|:---|:---|
| C000131667 | Fidelity MSCI Health Care Index ETF | FHLC            |

## Nport-Ex

### Quarterly Holdings Report

### for

### Fidelity® MSCI Health Care Index ETF

### April 30, 2025
T05-NPRT3-0625

1.9584810.111 ------

### Schedule of Investments April 30, 2025 (Unaudited)
Showing Percentage of Net Assets

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**Common Stocks – 99.7%** | &nbsp;&nbsp;**Common Stocks – 99.7%** | &nbsp;&nbsp;**Common Stocks – 99.7%** |
|  | &nbsp;&nbsp;**Shares** | &nbsp;&nbsp;**Value** |
| **BIOTECHNOLOGY – 20.0%** | **BIOTECHNOLOGY – 20.0%** | **BIOTECHNOLOGY – 20.0%** |
| **Biotechnology – 20.0%** | **Biotechnology – 20.0%** | **Biotechnology – 20.0%** |
| 89bio, Inc. (a) | &nbsp;&nbsp;46328 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$371551 |
| AbbVie, Inc. | 774740 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;151151774 |
| ACADIA Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;47759 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;697281 |
| ADMA Biologics, Inc. (a) | 103577 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2465133 |
| Agios Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;22514 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;668441 |
| Akero Therapeutics, Inc. (a) | &nbsp;&nbsp;21174 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;965746 |
| Akouos, Inc. (a) | &nbsp;&nbsp;11863 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2135 |
| Alkermes PLC (a) | &nbsp;&nbsp;67363 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1938034 |
| Alnylam Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;56542 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14884116 |
| Altimmune, Inc. (a) | &nbsp;&nbsp;30849 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;161957 |
| Amgen, Inc. | 235658 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;68557625 |
| Amicus Therapeutics, Inc. (a) | &nbsp;&nbsp;99203 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;761879 |
| AnaptysBio, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;7549 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;167739 |
| Anavex Life Sciences Corp. (a) | &nbsp;&nbsp;37156 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;352982 |
| Annexon, Inc. (a) | &nbsp;&nbsp;29991 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;55783 |
| Apellis Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;29990 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;576108 |
| Apogee Therapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;9813 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;385160 |
| Arbutus Biopharma Corp. (a) | &nbsp;&nbsp;61909 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;219777 |
| Arcellx, Inc. (a) | &nbsp;&nbsp;14356 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;932422 |
| Arcturus Therapeutics Holdings, Inc. (a) | &nbsp;&nbsp;10419 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;133467 |
| Arcus Biosciences, Inc. (a) | &nbsp;&nbsp;29905 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;261669 |
| Arcutis Biotherapeutics, Inc. (a) | &nbsp;&nbsp;45504 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;678465 |
| Ardelyx, Inc. (a) | 106702 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;587395 |
| ArriVent Biopharma, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;5852 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;124414 |
| Arrowhead Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;48843 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;678429 |
| ARS Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;17921 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;250356 |
| Astria Therapeutics, Inc. (a) | &nbsp;&nbsp;11134 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;57451 |
| Aurinia Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;53072 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;437313 |
| Avidity Biosciences, Inc. (a) | &nbsp;&nbsp;36593 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1194761 |
| Beam Therapeutics, Inc. (a) | &nbsp;&nbsp;39023 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;777728 |
| BioCryst Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;85820 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;759507 |
| Biogen, Inc. (a) | &nbsp;&nbsp;63886 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7735317 |
| Biohaven Ltd. (a) | &nbsp;&nbsp;37671 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;833283 |
| BioMarin Pharmaceutical, Inc. (a) | &nbsp;&nbsp;83418 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5312892 |
| Blueprint Medicines Corp. (a) | &nbsp;&nbsp;27943 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2500898 |
| Bridgebio Pharma, Inc. (a) | &nbsp;&nbsp;54155 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2077386 |
| Capricor Therapeutics, Inc. (a) | &nbsp;&nbsp;17931 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;227724 |
| CareDx, Inc. (a) | &nbsp;&nbsp;23155 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;390856 |
| Cargo Therapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;8026 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;36679 |
| Catalyst Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;47349 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1150107 |
| Celldex Therapeutics, Inc. (a) | &nbsp;&nbsp;26092 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;543496 |
| CG oncology, Inc. (a) | &nbsp;&nbsp;17871 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;481445 |
| Chinook Therapeutics, Inc. (a) | &nbsp;&nbsp;24218 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0 |
| Cogent Biosciences, Inc. (a) | &nbsp;&nbsp;31470 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;163959 |
| Crinetics Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;36569 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1221039 |
| CRISPR Therapeutics AG (a) | &nbsp;&nbsp;35766 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1383071 |
| Cullinan Therapeutics, Inc. (a) | &nbsp;&nbsp;13919 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;115249 |
| Cytokinetics, Inc. (a) | &nbsp;&nbsp;49391 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2115910 |

---

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;****  | &nbsp;&nbsp;****  | &nbsp;&nbsp;****  |
|  | &nbsp;&nbsp;**Shares** | &nbsp;&nbsp;**Value** |
| Day One Biopharmaceuticals, Inc. (a) | &nbsp;&nbsp;25318 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$196974 |
| Denali Therapeutics, Inc. (a) | &nbsp;&nbsp;56110 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;934231 |
| Disc Medicine, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;8084 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;399511 |
| Dynavax Technologies Corp. (a) | &nbsp;&nbsp;51373 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;603633 |
| Dyne Therapeutics, Inc. (a) | &nbsp;&nbsp;26763 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;315536 |
| Entrada Therapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;7990 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;72949 |
| Erasca, Inc. (a) | &nbsp;&nbsp;84048 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;122710 |
| Exact Sciences Corp. (a) | &nbsp;&nbsp;81208 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3706333 |
| Exelixis, Inc. (a) | 112797 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4416003 |
| Geron Corp. (a) | 223722 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;315448 |
| Gilead Sciences, Inc. | 546390 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;58212391 |
| GRAIL, Inc. (a) | &nbsp;&nbsp;13251 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;457093 |
| Halozyme Therapeutics, Inc. (a) | &nbsp;&nbsp;55654 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3418269 |
| Humacyte, Inc. (a) | &nbsp;&nbsp;53780 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;77981 |
| Ideaya Biosciences, Inc. (a) | &nbsp;&nbsp;34509 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;694666 |
| ImmunityBio, Inc. (a) | &nbsp;&nbsp;92823 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;232986 |
| Immunome, Inc. (a) | &nbsp;&nbsp;28546 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;250919 |
| Immunovant, Inc. (a) | &nbsp;&nbsp;29478 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;476070 |
| Incyte Corp. (a) | &nbsp;&nbsp;71991 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4510956 |
| Insmed, Inc. (a) | &nbsp;&nbsp;74459 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5361048 |
| Intellia Therapeutics, Inc. (a) | &nbsp;&nbsp;42137 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;373755 |
| Ionis Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;61962 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1902853 |
| Iovance Biotherapeutics, Inc. (a) | &nbsp;&nbsp;92768 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;333037 |
| Ironwood Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;61930 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;57737 |
| Janux Therapeutics, Inc. (a) | &nbsp;&nbsp;18517 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;614764 |
| Kiniksa Pharmaceuticals International PLC (a) | &nbsp;&nbsp;15968 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;430657 |
| Krystal Biotech, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;9410 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1598571 |
| Kura Oncology, Inc. (a) | &nbsp;&nbsp;19953 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;130892 |
| Kymera Therapeutics, Inc. (a) | &nbsp;&nbsp;16911 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;579540 |
| Madrigal Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;5781 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1930334 |
| MannKind Corp. (a) | 118580 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;597643 |
| Merus NV (a) | &nbsp;&nbsp;20841 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;948474 |
| MiMedx Group, Inc. (a) | &nbsp;&nbsp;50452 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;347110 |
| Mirum Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;15968 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;693810 |
| Moderna, Inc. (a) | 143764 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4103025 |
| MoonLake Immunotherapeutics (a) | &nbsp;&nbsp;&nbsp;&nbsp;9648 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;405988 |
| Myriad Genetics, Inc. (a) | &nbsp;&nbsp;39640 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;293732 |
| Natera, Inc. (a) | &nbsp;&nbsp;54981 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8298282 |
| Neurocrine Biosciences, Inc. (a) | &nbsp;&nbsp;44479 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4789944 |
| Newamsterdam Pharma Co. NV (a) | &nbsp;&nbsp;15969 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;305487 |
| Novavax, Inc. (a) | &nbsp;&nbsp;62904 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;419570 |
| Nurix Therapeutics, Inc. (a) | &nbsp;&nbsp;26379 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;304150 |
| Nuvalent, Inc. Class A (a) | &nbsp;&nbsp;16012 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1228921 |
| ORIC Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;14660 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;83709 |
| Praxis Precision Medicines, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;5947 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;223845 |
| Protagonist Therapeutics, Inc. (a) | &nbsp;&nbsp;19836 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;908886 |
| Prothena Corp. PLC (a) | &nbsp;&nbsp;15190 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;139748 |
| PTC Therapeutics, Inc. (a) | &nbsp;&nbsp;30592 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1524705 |
| Radius Health, Inc. (a) | &nbsp;&nbsp;20244 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0 |

---

 ***Quarterly Report*** <sub>2</sub>

------

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**Common Stocks – continued** | &nbsp;&nbsp;**Common Stocks – continued** | &nbsp;&nbsp;**Common Stocks – continued** | &nbsp;&nbsp;**Common Stocks – continued** |
|  |  | &nbsp;&nbsp;**Shares** | &nbsp;&nbsp;**Value** |
| **BIOTECHNOLOGY – continued** | **BIOTECHNOLOGY – continued** | **BIOTECHNOLOGY – continued** | **BIOTECHNOLOGY – continued** |
| **Biotechnology – continued** | **Biotechnology – continued** | **Biotechnology – continued** | **Biotechnology – continued** |
| Recursion Pharmaceuticals, Inc. Class A (a) | Recursion Pharmaceuticals, Inc. Class A (a) | 108041 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$603949 |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. | &nbsp;&nbsp;47379 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28368650 |
| Relay Therapeutics, Inc. (a) | Relay Therapeutics, Inc. (a) | &nbsp;&nbsp;50830 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;169264 |
| Replimune Group, Inc. (a) | Replimune Group, Inc. (a) | &nbsp;&nbsp;22989 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;224832 |
| Revolution Medicines, Inc. (a) | Revolution Medicines, Inc. (a) | &nbsp;&nbsp;62563 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2526294 |
| Rhythm Pharmaceuticals, Inc. (a) | Rhythm Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;20193 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1316382 |
| Rocket Pharmaceuticals, Inc. (a) | Rocket Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;34110 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;260259 |
| Roivant Sciences Ltd. (a) | Roivant Sciences Ltd. (a) | 159045 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1848103 |
| Sana Biotechnology, Inc. (a) | Sana Biotechnology, Inc. (a) | &nbsp;&nbsp;51005 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;96909 |
| Sarepta Therapeutics, Inc. (a) | Sarepta Therapeutics, Inc. (a) | &nbsp;&nbsp;37741 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2355038 |
| Savara, Inc. (a) | Savara, Inc. (a) | &nbsp;&nbsp;43023 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;137674 |
| Scholar Rock Holding Corp. (a) | Scholar Rock Holding Corp. (a) | &nbsp;&nbsp;28710 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;944846 |
| Soleno Therapeutics, Inc. (a) | Soleno Therapeutics, Inc. (a) | &nbsp;&nbsp;11324 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;847715 |
| SpringWorks Therapeutics, Inc. (a) | SpringWorks Therapeutics, Inc. (a) | &nbsp;&nbsp;25952 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1201578 |
| Spyre Therapeutics, Inc. (a) | Spyre Therapeutics, Inc. (a) | &nbsp;&nbsp;15233 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;231999 |
| Stoke Therapeutics, Inc. (a) | Stoke Therapeutics, Inc. (a) | &nbsp;&nbsp;14947 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;145883 |
| Syndax Pharmaceuticals, Inc. (a) | Syndax Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;33244 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;470403 |
| TG Therapeutics, Inc. (a) | TG Therapeutics, Inc. (a) | &nbsp;&nbsp;64601 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2939992 |
| Tourmaline Bio, Inc. (a) | Tourmaline Bio, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;4471 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;76946 |
| Travere Therapeutics, Inc. (a) | Travere Therapeutics, Inc. (a) | &nbsp;&nbsp;35738 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;743708 |
| Twist Bioscience Corp. (a) | Twist Bioscience Corp. (a) | &nbsp;&nbsp;25839 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;990150 |
| Tyra Biosciences, Inc. (a) | Tyra Biosciences, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;6640 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;68392 |
| Ultragenyx Pharmaceutical, Inc. (a) | Ultragenyx Pharmaceutical, Inc. (a) | &nbsp;&nbsp;36223 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1411973 |
| United Therapeutics Corp. (a) | United Therapeutics Corp. (a) | &nbsp;&nbsp;18580 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5631412 |
| Vaxcyte, Inc. (a) | Vaxcyte, Inc. (a) | &nbsp;&nbsp;49152 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1761608 |
| Vera Therapeutics, Inc. (a) | Vera Therapeutics, Inc. (a) | &nbsp;&nbsp;20060 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;468802 |
| Veracyte, Inc. (a) | Veracyte, Inc. (a) | &nbsp;&nbsp;33775 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1030137 |
| Vericel Corp. (a) | Vericel Corp. (a) | &nbsp;&nbsp;21422 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;814464 |
| Vertex Pharmaceuticals, Inc. (a) | Vertex Pharmaceuticals, Inc. (a) | 112905 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;57525097 |
| Verve Therapeutics, Inc. (a) | Verve Therapeutics, Inc. (a) | &nbsp;&nbsp;26887 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;152449 |
| Viking Therapeutics, Inc. (a) | Viking Therapeutics, Inc. (a) | &nbsp;&nbsp;44339 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1280067 |
| Vir Biotechnology, Inc. (a) | Vir Biotechnology, Inc. (a) | &nbsp;&nbsp;40126 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;245571 |
| Viridian Therapeutics, Inc. (a) | Viridian Therapeutics, Inc. (a) | &nbsp;&nbsp;23647 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;320417 |
| Xencor, Inc. (a) | Xencor, Inc. (a) | &nbsp;&nbsp;25832 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;284669 |
| Xenon Pharmaceuticals, Inc. (a) | Xenon Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;28609 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1092864 |
| Zymeworks, Inc. (a) | Zymeworks, Inc. (a) | &nbsp;&nbsp;18114 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;235663 |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;514714944 |
| **Pharmaceuticals – 0.0%** | **Pharmaceuticals – 0.0%** | **Pharmaceuticals – 0.0%** | **Pharmaceuticals – 0.0%** |
| LENZ Therapeutics, Inc. (a) | LENZ Therapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;5335 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;152127 |
| TOTAL BIOTECHNOLOGY | &nbsp;&nbsp;&nbsp;&nbsp;514867071 |  |  |
| **HEALTH CARE EQUIPMENT & SUPPLIES – 21.7%** | **HEALTH CARE EQUIPMENT & SUPPLIES – 21.7%** | **HEALTH CARE EQUIPMENT & SUPPLIES – 21.7%** | **HEALTH CARE EQUIPMENT & SUPPLIES – 21.7%** |
| **Health Care Equipment – 20.5%** | **Health Care Equipment – 20.5%** | **Health Care Equipment – 20.5%** | **Health Care Equipment – 20.5%** |
| Abbott Laboratories | Abbott Laboratories | 760418 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;99424653 |
| Alphatec Holdings, Inc. (a) | Alphatec Holdings, Inc. (a) | &nbsp;&nbsp;45853 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;503466 |
| Artivion, Inc. (a) | Artivion, Inc. (a) | &nbsp;&nbsp;16553 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;392141 |
| AtriCure, Inc. (a) | AtriCure, Inc. (a) | &nbsp;&nbsp;21418 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;640612 |
| Axogen, Inc. (a) | Axogen, Inc. (a) | &nbsp;&nbsp;18307 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;297855 |
| Baxter International, Inc. | Baxter International, Inc. | 223855 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6977560 |

---

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;****  | &nbsp;&nbsp;****  | &nbsp;&nbsp;****  |
|  | &nbsp;&nbsp;**Shares** | &nbsp;&nbsp;**Value** |
| Becton Dickinson & Co. | 127147 | &nbsp;&nbsp;&nbsp;&nbsp;$26330872 |
| Boston Scientific Corp. (a) | 646158 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;66470273 |
| Butterfly Network, Inc. (a) | &nbsp;&nbsp;61325 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;143501 |
| Ceribell, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;5495 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;88415 |
| CONMED Corp. | &nbsp;&nbsp;13793 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;677374 |
| Dexcom, Inc. (a) | 171242 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12223254 |
| Edwards Lifesciences Corp. (a) | 258578 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;19520053 |
| Enovis Corp. (a) | &nbsp;&nbsp;24455 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;845898 |
| Envista Holdings Corp. (a) | &nbsp;&nbsp;76353 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1227756 |
| GE HealthCare Technologies, Inc. | 200303 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14087310 |
| Glaukos Corp. (a) | &nbsp;&nbsp;24219 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2282641 |
| Globus Medical, Inc. Class A (a) | &nbsp;&nbsp;49877 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3579672 |
| Hologic, Inc. (a) | &nbsp;&nbsp;99429 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5786768 |
| IDEXX Laboratories, Inc. (a) | &nbsp;&nbsp;35901 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15532568 |
| Inspire Medical Systems, Inc. (a) | &nbsp;&nbsp;13111 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2076520 |
| Insulet Corp. (a) | &nbsp;&nbsp;30770 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7762963 |
| Integer Holdings Corp. (a) | &nbsp;&nbsp;14706 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1857515 |
| Integra LifeSciences Holdings Corp. (a) | &nbsp;&nbsp;30431 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;498764 |
| Intuitive Surgical, Inc. (a) | 156161 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;80547844 |
| iRadimed Corp. | &nbsp;&nbsp;&nbsp;&nbsp;3219 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;168708 |
| iRhythm Technologies, Inc. (a) | &nbsp;&nbsp;13631 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1457018 |
| LeMaitre Vascular, Inc. | &nbsp;&nbsp;&nbsp;&nbsp;8958 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;812849 |
| LivaNova PLC (a) | &nbsp;&nbsp;23670 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;875790 |
| Masimo Corp. (a) | &nbsp;&nbsp;19933 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3208416 |
| Medtronic PLC | 562173 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;47649783 |
| Novocure Ltd. (a) | &nbsp;&nbsp;44906 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;814595 |
| Omnicell, Inc. (a) | &nbsp;&nbsp;20343 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;635922 |
| Orthofix Medical, Inc. (a) | &nbsp;&nbsp;14513 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;201876 |
| Penumbra, Inc. (a) | &nbsp;&nbsp;16060 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4703010 |
| PROCEPT BioRobotics Corp. (a) | &nbsp;&nbsp;22520 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1215630 |
| Pulse Biosciences, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;5389 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;91721 |
| QuidelOrtho Corp. (a) | &nbsp;&nbsp;29348 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;815581 |
| ResMed, Inc. | &nbsp;&nbsp;64353 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15225276 |
| SI-BONE, Inc. (a) | &nbsp;&nbsp;16569 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;226167 |
| STERIS PLC | &nbsp;&nbsp;43269 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9724275 |
| Stryker Corp. | 150420 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;56245046 |
| Tandem Diabetes Care, Inc. (a) | &nbsp;&nbsp;28883 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;486679 |
| Teleflex, Inc. | &nbsp;&nbsp;20353 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2789379 |
| TransMedics Group, Inc. (a) | &nbsp;&nbsp;14660 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1348867 |
| Varex Imaging Corp. (a) | &nbsp;&nbsp;17526 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;145816 |
| Zimmer Biomet Holdings, Inc. | &nbsp;&nbsp;87278 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8993998 |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;527612650 |
| **Health Care Supplies – 1.2%** | **Health Care Supplies – 1.2%** | **Health Care Supplies – 1.2%** |
| Align Technology, Inc. (a) | &nbsp;&nbsp;31151 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5398468 |
| Avanos Medical, Inc. (a) | &nbsp;&nbsp;20107 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;252343 |
| Bioventus, Inc. Class A (a) | &nbsp;&nbsp;15657 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;114453 |
| Cooper Cos., Inc. (a) | &nbsp;&nbsp;87505 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7146533 |
| Dentsply Sirona, Inc. | &nbsp;&nbsp;86806 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1206603 |
| Embecta Corp. | &nbsp;&nbsp;24537 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;299106 |
| Establishment Labs Holdings, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;8985 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;272695 |

---

---

| | |
|:---|:---|
| **3** | ***Quarterly Report*** |

---

------

Schedule of Investments (Unaudited)–continued

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**Common Stocks – continued** | &nbsp;&nbsp;**Common Stocks – continued** | &nbsp;&nbsp;**Common Stocks – continued** | &nbsp;&nbsp;**Common Stocks – continued** |
|  |  | &nbsp;&nbsp;**Shares** | &nbsp;&nbsp;**Value** |
| **HEALTH CARE EQUIPMENT & SUPPLIES – continued** | **HEALTH CARE EQUIPMENT & SUPPLIES – continued** | **HEALTH CARE EQUIPMENT & SUPPLIES – continued** | **HEALTH CARE EQUIPMENT & SUPPLIES – continued** |
| **Health Care Supplies – continued** | **Health Care Supplies – continued** | **Health Care Supplies – continued** | **Health Care Supplies – continued** |
| Haemonetics Corp. (a) | Haemonetics Corp. (a) | &nbsp;&nbsp;21961 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$1383982 |
| ICU Medical, Inc. (a) | ICU Medical, Inc. (a) | &nbsp;&nbsp;10118 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1382018 |
| Lantheus Holdings, Inc. (a) | Lantheus Holdings, Inc. (a) | &nbsp;&nbsp;30599 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3192700 |
| Merit Medical Systems, Inc. (a) | Merit Medical Systems, Inc. (a) | &nbsp;&nbsp;25590 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2416976 |
| Neogen Corp. (a) | Neogen Corp. (a) | &nbsp;&nbsp;89680 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;452884 |
| OrthoPediatrics Corp. (a) | OrthoPediatrics Corp. (a) | &nbsp;&nbsp;&nbsp;&nbsp;7399 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;154047 |
| RxSight, Inc. (a) | RxSight, Inc. (a) | &nbsp;&nbsp;15378 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;226364 |
| Solventum Corp. (a) | Solventum Corp. (a) | &nbsp;&nbsp;64267 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4249334 |
| STAAR Surgical Co. (a) | STAAR Surgical Co. (a) | &nbsp;&nbsp;16748 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;305818 |
| UFP Technologies, Inc. (a) | UFP Technologies, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;3360 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;700694 |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29155018 |
| TOTAL HEALTH CARE EQUIPMENT & SUPPLIES | &nbsp;&nbsp;&nbsp;&nbsp;556767668 |  |  |
| **HEALTH CARE PROVIDERS & SERVICES – 19.6%** | **HEALTH CARE PROVIDERS & SERVICES – 19.6%** | **HEALTH CARE PROVIDERS & SERVICES – 19.6%** | **HEALTH CARE PROVIDERS & SERVICES – 19.6%** |
| **Health Care Distributors – 3.1%** | **Health Care Distributors – 3.1%** | **Health Care Distributors – 3.1%** | **Health Care Distributors – 3.1%** |
| AdaptHealth Corp. (a) | AdaptHealth Corp. (a) | &nbsp;&nbsp;37816 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;321814 |
| Cardinal Health, Inc. | Cardinal Health, Inc. | 106104 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14991434 |
| Cencora, Inc. | Cencora, Inc. | &nbsp;&nbsp;76262 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22319600 |
| Henry Schein, Inc. (a) | Henry Schein, Inc. (a) | &nbsp;&nbsp;54634 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3549571 |
| McKesson Corp. | McKesson Corp. | &nbsp;&nbsp;55659 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;39673179 |
| Owens & Minor, Inc. (a) | Owens & Minor, Inc. (a) | &nbsp;&nbsp;30973 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;218669 |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;81074267 |
| **Health Care Facilities – 2.1%** | **Health Care Facilities – 2.1%** | **Health Care Facilities – 2.1%** | **Health Care Facilities – 2.1%** |
| Acadia Healthcare Co., Inc. (a) | Acadia Healthcare Co., Inc. (a) | &nbsp;&nbsp;40530 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;948402 |
| Brookdale Senior Living, Inc. (a) | Brookdale Senior Living, Inc. (a) | &nbsp;&nbsp;81405 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;534017 |
| Concentra Group Holdings Parent, Inc. | Concentra Group Holdings Parent, Inc. | &nbsp;&nbsp;50242 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1092764 |
| Encompass Health Corp. | Encompass Health Corp. | &nbsp;&nbsp;44104 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5159727 |
| Ensign Group, Inc. | Ensign Group, Inc. | &nbsp;&nbsp;25101 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3237778 |
| HCA Healthcare, Inc. | HCA Healthcare, Inc. | &nbsp;&nbsp;83286 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;28740333 |
| National HealthCare Corp. | National HealthCare Corp. | &nbsp;&nbsp;&nbsp;&nbsp;5760 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;544262 |
| PACS Group, Inc. (a) | PACS Group, Inc. (a) | &nbsp;&nbsp;20329 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;195768 |
| Select Medical Holdings Corp. | Select Medical Holdings Corp. | &nbsp;&nbsp;48591 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;886300 |
| Surgery Partners, Inc. (a) | Surgery Partners, Inc. (a) | &nbsp;&nbsp;30238 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;663724 |
| Tenet Healthcare Corp. (a) | Tenet Healthcare Corp. (a) | &nbsp;&nbsp;41775 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5971736 |
| U.S. Physical Therapy, Inc. | U.S. Physical Therapy, Inc. | &nbsp;&nbsp;&nbsp;&nbsp;6601 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;469397 |
| Universal Health Services, Inc. Class B | Universal Health Services, Inc. Class B | &nbsp;&nbsp;25727 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4555480 |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;52999688 |
| **Health Care Services – 4.7%** | **Health Care Services – 4.7%** | **Health Care Services – 4.7%** | **Health Care Services – 4.7%** |
| Addus HomeCare Corp. (a) | Addus HomeCare Corp. (a) | &nbsp;&nbsp;&nbsp;&nbsp;7923 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;828350 |
| agilon health, Inc. (a) | agilon health, Inc. (a) | 138767 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;591147 |
| Amedisys, Inc. (a) | Amedisys, Inc. (a) | &nbsp;&nbsp;14273 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1354508 |
| AMN Healthcare Services, Inc. (a) | AMN Healthcare Services, Inc. (a) | &nbsp;&nbsp;16465 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;336380 |
| Astrana Health, Inc. (a) | Astrana Health, Inc. (a) | &nbsp;&nbsp;20051 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;624990 |
| Aveanna Healthcare Holdings, Inc. (a) | Aveanna Healthcare Holdings, Inc. (a) | &nbsp;&nbsp;21094 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;97243 |
| BrightSpring Health Services, Inc. (a) | BrightSpring Health Services, Inc. (a) | &nbsp;&nbsp;26184 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;459005 |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;****  | &nbsp;&nbsp;****  | &nbsp;&nbsp;****  | &nbsp;&nbsp;****  |
|  |  | &nbsp;&nbsp;**Shares** | &nbsp;&nbsp;**Value** |
| Castle Biosciences, Inc. (a) | Castle Biosciences, Inc. (a) | &nbsp;&nbsp;11835 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$237292 |
| Chemed Corp. | Chemed Corp. | &nbsp;&nbsp;&nbsp;&nbsp;6243 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3630367 |
| Cigna Group | Cigna Group | 121941 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;41464818 |
| CorVel Corp. (a) | CorVel Corp. (a) | &nbsp;&nbsp;12351 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1343295 |
| Cross Country Healthcare, Inc. (a) | Cross Country Healthcare, Inc. (a) | &nbsp;&nbsp;12019 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;162857 |
| CVS Health Corp. | CVS Health Corp. | 551711 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;36804641 |
| DaVita, Inc. (a) | DaVita, Inc. (a) | &nbsp;&nbsp;19770 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2798443 |
| Fulgent Genetics, Inc. (a) | Fulgent Genetics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;9602 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;166595 |
| GeneDx Holdings Corp. (a) | GeneDx Holdings Corp. (a) | &nbsp;&nbsp;&nbsp;&nbsp;7229 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;483259 |
| Guardant Health, Inc. (a) | Guardant Health, Inc. (a) | &nbsp;&nbsp;54511 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2574555 |
| Hims & Hers Health, Inc. (a) | Hims & Hers Health, Inc. (a) | &nbsp;&nbsp;78261 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2590439 |
| Labcorp Holdings, Inc. | Labcorp Holdings, Inc. | &nbsp;&nbsp;36670 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8837837 |
| LifeStance Health Group, Inc. (a) | LifeStance Health Group, Inc. (a) | &nbsp;&nbsp;58499 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;384338 |
| NeoGenomics, Inc. (a) | NeoGenomics, Inc. (a) | &nbsp;&nbsp;55697 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;356182 |
| OPKO Health, Inc. (a) | OPKO Health, Inc. (a) | 151815 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;209505 |
| Option Care Health, Inc. (a) | Option Care Health, Inc. (a) | &nbsp;&nbsp;74471 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2406158 |
| Pediatrix Medical Group, Inc. (a) | Pediatrix Medical Group, Inc. (a) | &nbsp;&nbsp;37871 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;487778 |
| Pennant Group, Inc. (a) | Pennant Group, Inc. (a) | &nbsp;&nbsp;15646 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;400850 |
| Premier, Inc. Class A | Premier, Inc. Class A | &nbsp;&nbsp;42113 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;857000 |
| Privia Health Group, Inc. (a) | Privia Health Group, Inc. (a) | &nbsp;&nbsp;42255 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;992147 |
| Quest Diagnostics, Inc. | Quest Diagnostics, Inc. | &nbsp;&nbsp;48932 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8720661 |
| RadNet, Inc. (a) | RadNet, Inc. (a) | &nbsp;&nbsp;27721 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1452026 |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;121652666 |
| **Managed Health Care – 9.7%** | **Managed Health Care – 9.7%** | **Managed Health Care – 9.7%** | **Managed Health Care – 9.7%** |
| Alignment Healthcare, Inc. (a) | Alignment Healthcare, Inc. (a) | &nbsp;&nbsp;42402 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;751363 |
| Centene Corp. (a) | Centene Corp. (a) | 221344 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13247438 |
| Clover Health Investments Corp. (a) | Clover Health Investments Corp. (a) | 171534 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;583216 |
| Elevance Health, Inc. | Elevance Health, Inc. | 101672 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;42761210 |
| HealthEquity, Inc. (a) | HealthEquity, Inc. (a) | &nbsp;&nbsp;38085 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3264646 |
| Humana, Inc. | Humana, Inc. | &nbsp;&nbsp;52787 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13842863 |
| Molina Healthcare, Inc. (a) | Molina Healthcare, Inc. (a) | &nbsp;&nbsp;25067 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8197160 |
| Progyny, Inc. (a) | Progyny, Inc. (a) | &nbsp;&nbsp;31707 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;724188 |
| UnitedHealth Group, Inc. | UnitedHealth Group, Inc. | 403468 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;166002874 |
|  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;249374958 |
| TOTAL HEALTH CARE PROVIDERS & SERVICES | &nbsp;&nbsp;&nbsp;&nbsp;505101579 |  |  |
| **HEALTH CARE TECHNOLOGY – 0.9%** | **HEALTH CARE TECHNOLOGY – 0.9%** | **HEALTH CARE TECHNOLOGY – 0.9%** | **HEALTH CARE TECHNOLOGY – 0.9%** |
| **Health Care Technology – 0.9%** | **Health Care Technology – 0.9%** | **Health Care Technology – 0.9%** | **Health Care Technology – 0.9%** |
| Certara, Inc. (a) | Certara, Inc. (a) | &nbsp;&nbsp;56442 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;782286 |
| Definitive Healthcare Corp. (a) | Definitive Healthcare Corp. (a) | &nbsp;&nbsp;22128 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;60188 |
| Doximity, Inc. Class A (a) | Doximity, Inc. Class A (a) | &nbsp;&nbsp;47729 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2714826 |
| Evolent Health, Inc. Class A (a) | Evolent Health, Inc. Class A (a) | &nbsp;&nbsp;43218 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;426130 |
| GoodRx Holdings, Inc. Class A (a) | GoodRx Holdings, Inc. Class A (a) | &nbsp;&nbsp;40181 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;186038 |
| HealthStream, Inc. | HealthStream, Inc. | &nbsp;&nbsp;10591 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;356175 |
| Phreesia, Inc. (a) | Phreesia, Inc. (a) | &nbsp;&nbsp;24152 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;602834 |
| Schrodinger, Inc. (a) | Schrodinger, Inc. (a) | &nbsp;&nbsp;27492 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;704620 |
| Simulations Plus, Inc. | Simulations Plus, Inc. | &nbsp;&nbsp;&nbsp;&nbsp;7329 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;251751 |
| Teladoc Health, Inc. (a) | Teladoc Health, Inc. (a) | &nbsp;&nbsp;74394 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;534893 |
| Veeva Systems, Inc. Class A (a) | Veeva Systems, Inc. Class A (a) | &nbsp;&nbsp;67616 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15801183 |

---

 ***Quarterly Report*** <sub>4</sub>

------

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**Common Stocks – continued** | &nbsp;&nbsp;**Common Stocks – continued** | &nbsp;&nbsp;**Common Stocks – continued** | &nbsp;&nbsp;**Common Stocks – continued** |
|  |  | &nbsp;&nbsp;**Shares** | &nbsp;&nbsp;**Value** |
| **HEALTH CARE TECHNOLOGY – continued** | **HEALTH CARE TECHNOLOGY – continued** | **HEALTH CARE TECHNOLOGY – continued** | **HEALTH CARE TECHNOLOGY – continued** |
| **Health Care Technology – continued** | **Health Care Technology – continued** | **Health Care Technology – continued** | **Health Care Technology – continued** |
| Waystar Holding Corp. (a) | Waystar Holding Corp. (a) | &nbsp;&nbsp;30154 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$1120824 |
| TOTAL HEALTH CARE TECHNOLOGY | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23541748 |  |  |
| **LIFE SCIENCES TOOLS & SERVICES – 8.4%** | **LIFE SCIENCES TOOLS & SERVICES – 8.4%** | **LIFE SCIENCES TOOLS & SERVICES – 8.4%** | **LIFE SCIENCES TOOLS & SERVICES – 8.4%** |
| **Life Sciences Tools & Services – 8.4%** | **Life Sciences Tools & Services – 8.4%** | **Life Sciences Tools & Services – 8.4%** | **Life Sciences Tools & Services – 8.4%** |
| 10X Genomics, Inc. Class A (a) | 10X Genomics, Inc. Class A (a) | &nbsp;&nbsp;41440 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;342709 |
| Adaptive Biotechnologies Corp. (a) | Adaptive Biotechnologies Corp. (a) | &nbsp;&nbsp;45069 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;331708 |
| Agilent Technologies, Inc. | Agilent Technologies, Inc. | 125207 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13472273 |
| Avantor, Inc. (a) | Avantor, Inc. (a) | 298379 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3875943 |
| Azenta, Inc. (a) | Azenta, Inc. (a) | &nbsp;&nbsp;18022 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;474699 |
| BioLife Solutions, Inc. (a) | BioLife Solutions, Inc. (a) | &nbsp;&nbsp;16473 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;397164 |
| Bio-Rad Laboratories, Inc. Class A (a) | Bio-Rad Laboratories, Inc. Class A (a) | &nbsp;&nbsp;&nbsp;&nbsp;8558 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2088837 |
| Bio-Techne Corp. | Bio-Techne Corp. | &nbsp;&nbsp;69721 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3510452 |
| Bruker Corp. | Bruker Corp. | &nbsp;&nbsp;46346 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1856621 |
| Charles River Laboratories International, Inc. (a) | Charles River Laboratories International, Inc. (a) | &nbsp;&nbsp;22355 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2651750 |
| Cytek Biosciences, Inc. (a) | Cytek Biosciences, Inc. (a) | &nbsp;&nbsp;50418 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;187051 |
| Danaher Corp. | Danaher Corp. | 284991 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;56807256 |
| Fortrea Holdings, Inc. (a) | Fortrea Holdings, Inc. (a) | &nbsp;&nbsp;38076 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;237213 |
| Illumina, Inc. (a) | Illumina, Inc. (a) | &nbsp;&nbsp;69720 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5410272 |
| IQVIA Holdings, Inc. (a) | IQVIA Holdings, Inc. (a) | &nbsp;&nbsp;79575 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12339695 |
| Maravai LifeSciences Holdings, Inc. Class A (a) | Maravai LifeSciences Holdings, Inc. Class A (a) | &nbsp;&nbsp;49347 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;99681 |
| Medpace Holdings, Inc. (a) | Medpace Holdings, Inc. (a) | &nbsp;&nbsp;11611 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3580716 |
| Mesa Laboratories, Inc. | Mesa Laboratories, Inc. | &nbsp;&nbsp;&nbsp;&nbsp;2437 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;280864 |
| Mettler-Toledo International, Inc. (a) | Mettler-Toledo International, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;9250 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9902773 |
| OmniAb, Inc. (a) | OmniAb, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;3335 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7170 |
| OmniAb, Inc. (a) | OmniAb, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;3335 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6370 |
| Pacific Biosciences of California, Inc. (a) | Pacific Biosciences of California, Inc. (a) | 103826 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;115247 |
| Repligen Corp. (a) | Repligen Corp. (a) | &nbsp;&nbsp;23341 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3220825 |
| Revvity, Inc. | Revvity, Inc. | &nbsp;&nbsp;53337 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4983276 |
| Sotera Health Co. (a) | Sotera Health Co. (a) | &nbsp;&nbsp;68021 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;782242 |
| Standard BioTools, Inc. (a) | Standard BioTools, Inc. (a) | &nbsp;&nbsp;95587 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;106102 |
| Thermo Fisher Scientific, Inc. | Thermo Fisher Scientific, Inc. | 167698 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;71942442 |
| Waters Corp. (a) | Waters Corp. (a) | &nbsp;&nbsp;26043 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9055932 |
| West Pharmaceutical Services, Inc. | West Pharmaceutical Services, Inc. | &nbsp;&nbsp;31752 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6708880 |
| TOTAL LIFE SCIENCES TOOLS & SERVICES | &nbsp;&nbsp;&nbsp;&nbsp;214776163 |  |  |
| **PHARMACEUTICALS – 29.1%** | **PHARMACEUTICALS – 29.1%** | **PHARMACEUTICALS – 29.1%** | **PHARMACEUTICALS – 29.1%** |
| **Pharmaceuticals – 29.1%** | **Pharmaceuticals – 29.1%** | **Pharmaceuticals – 29.1%** | **Pharmaceuticals – 29.1%** |
| Amneal Pharmaceuticals, Inc. (a) | Amneal Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;60822 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;465897 |
| Amphastar Pharmaceuticals, Inc. (a) | Amphastar Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;16856 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;411455 |
| ANI Pharmaceuticals, Inc. (a) | ANI Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;7517 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;532354 |
| Arvinas, Inc. (a) | Arvinas, Inc. (a) | &nbsp;&nbsp;20804 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;200134 |
| Avadel Pharmaceuticals PLC (a) | Avadel Pharmaceuticals PLC (a) | &nbsp;&nbsp;37818 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;336202 |
| Axsome Therapeutics, Inc. (a) | Axsome Therapeutics, Inc. (a) | &nbsp;&nbsp;13833 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1553308 |
| Bristol-Myers Squibb Co. | Bristol-Myers Squibb Co. | 889195 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;44637589 |

---

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;****  | &nbsp;&nbsp;****  | &nbsp;&nbsp;****  | &nbsp;&nbsp;****  |
|  |  | &nbsp;&nbsp;**Shares** | &nbsp;&nbsp;**Value** |
| Collegium Pharmaceutical, Inc. (a) | Collegium Pharmaceutical, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;14107 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$380818 |
| Corcept Therapeutics, Inc. (a) | Corcept Therapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;41247 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2964834 |
| CorMedix, Inc. (a) | CorMedix, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;26590 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;244362 |
| Edgewise Therapeutics, Inc. (a) | Edgewise Therapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;20643 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;338545 |
| Elanco Animal Health, Inc. (a) | Elanco Animal Health, Inc. (a) | &nbsp;&nbsp;&nbsp;218059 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2067199 |
| Eli Lilly & Co. | Eli Lilly & Co. | &nbsp;&nbsp;&nbsp;353769 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;318020643 |
| Enliven Therapeutics, Inc. (a) | Enliven Therapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9279 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;175744 |
| Evolus, Inc. (a) | Evolus, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;20556 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;234338 |
| EyePoint Pharmaceuticals, Inc. (a) | EyePoint Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;26794 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;182735 |
| Harmony Biosciences Holdings, Inc. (a) | Harmony Biosciences Holdings, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;18743 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;552356 |
| Harrow, Inc. (a) | Harrow, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;13137 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;325404 |
| Innoviva, Inc. (a) | Innoviva, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;24364 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;455363 |
| Jazz Pharmaceuticals PLC (a) | Jazz Pharmaceuticals PLC (a) | &nbsp;&nbsp;&nbsp;&nbsp;25172 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2944117 |
| Johnson & Johnson | Johnson & Johnson | 1055545 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;164992239 |
| Ligand Pharmaceuticals, Inc. (a) | Ligand Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8327 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;914804 |
| Liquidia Corp. (a) | Liquidia Corp. (a) | &nbsp;&nbsp;&nbsp;&nbsp;22161 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;309589 |
| Merck & Co., Inc. | Merck & Co., Inc. | 1109033 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;94489612 |
| Mind Medicine MindMed, Inc. (a) | Mind Medicine MindMed, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;23776 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;151929 |
| Nuvation Bio, Inc. (a) | Nuvation Bio, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;94718 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;213116 |
| Ocular Therapeutix, Inc. (a) | Ocular Therapeutix, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;40758 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;338291 |
| Organon & Co. | Organon & Co. | &nbsp;&nbsp;&nbsp;113628 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1469210 |
| Pacira BioSciences, Inc. (a) | Pacira BioSciences, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;19895 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;535176 |
| Perrigo Co. PLC | Perrigo Co. PLC | &nbsp;&nbsp;&nbsp;&nbsp;60280 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1550402 |
| Pfizer, Inc. | Pfizer, Inc. | 2484515 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;60647011 |
| Phathom Pharmaceuticals, Inc. (a) | Phathom Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;16406 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;70382 |
| Phibro Animal Health Corp. Class A | Phibro Animal Health Corp. Class A | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8948 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;166522 |
| Pliant Therapeutics, Inc. (a) | Pliant Therapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;21625 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;34384 |
| Prestige Consumer Healthcare, Inc. (a) | Prestige Consumer Healthcare, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;21681 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1761148 |
| Rapport Therapeutics, Inc. (a) | Rapport Therapeutics, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7218 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;82646 |
| Royalty Pharma PLC Class A | Royalty Pharma PLC Class A | &nbsp;&nbsp;&nbsp;165486 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5431251 |
| Scilex Holding Co. (a) | Scilex Holding Co. (a) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;998 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4729 |
| Septerna, Inc. (a) | Septerna, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6803 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;47349 |
| SIGA Technologies, Inc. | SIGA Technologies, Inc. | &nbsp;&nbsp;&nbsp;&nbsp;19595 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;108164 |
| Supernus Pharmaceuticals, Inc. (a) | Supernus Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;24180 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;785366 |
| Tarsus Pharmaceuticals, Inc. (a) | Tarsus Pharmaceuticals, Inc. (a) | &nbsp;&nbsp;&nbsp;&nbsp;12565 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;652249 |
| Tilray Brands, Inc. (a) | Tilray Brands, Inc. (a) | &nbsp;&nbsp;&nbsp;409080 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;198445 |
| Viatris, Inc. | Viatris, Inc. | &nbsp;&nbsp;&nbsp;522026 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4395459 |
| WaVe Life Sciences Ltd. (a) | WaVe Life Sciences Ltd. (a) | &nbsp;&nbsp;&nbsp;&nbsp;43433 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;335303 |
| Zoetis, Inc. | Zoetis, Inc. | &nbsp;&nbsp;&nbsp;197798 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30935607 |
| TOTAL PHARMACEUTICALS | &nbsp;&nbsp;&nbsp;&nbsp;747643780 |  |  |
| **TOTAL COMMON STOCKS<br> (Cost $2,138,905,459)** | **TOTAL COMMON STOCKS<br> (Cost $2,138,905,459)** | **TOTAL COMMON STOCKS<br> (Cost $2,138,905,459)** | &nbsp;&nbsp;**2562698009** |

---

---

| | |
|:---|:---|
| **5** | ***Quarterly Report*** |

---

------

Schedule of Investments (Unaudited)–continued

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**Money Market Fund – 0.2%** | &nbsp;&nbsp;**Money Market Fund – 0.2%** | &nbsp;&nbsp;**Money Market Fund – 0.2%** | &nbsp;&nbsp;**Money Market Fund – 0.2%** |
|  |  | &nbsp;&nbsp;**Shares** | &nbsp;&nbsp;**Value** |
| State Street Institutional Treasury Plus Money Market Fund, Trust Class, 4.22% (b)<br> (Cost $5,844,000) | State Street Institutional Treasury Plus Money Market Fund, Trust Class, 4.22% (b)<br> (Cost $5,844,000) | 5844000 | &nbsp;&nbsp;&nbsp;&nbsp;$5844000 |
| **TOTAL INVESTMENT IN SECURITIES – 99.9%<br> (Cost $2,144,749,459)** | &nbsp;&nbsp;**2568542009** |  |  |
| **NET OTHER ASSETS (LIABILITIES) (c) – 0.1%** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3287036** |  |  |
| **NET ASSETS – 100.0%** | **$2571829045** |  |  |

---

---

| | |
|:---|:---|
| **Legend** | **Legend** |
| (a) | Non-income producing. |
| (b) | The rate quoted is the annualized seven-day yield of the fund at period end. |
| (c) | Includes $529,126 of cash collateral to cover margin requirements for futures contracts. |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;**Futures Contracts** | &nbsp;&nbsp;**Futures Contracts** | &nbsp;&nbsp;**Futures Contracts** | &nbsp;&nbsp;**Futures Contracts** | &nbsp;&nbsp;**Futures Contracts** | &nbsp;&nbsp;**Futures Contracts** |
|  | **Number of<br> contracts** | &nbsp;&nbsp;**Expiration<br> Date** | &nbsp;&nbsp;**Notional<br> Amount** | &nbsp;&nbsp;**Value** | &nbsp;&nbsp;**Unrealized<br> Appreciation/<br> (Depreciation)** |
| **Purchased** |  |  |  |  |  |
| **Equity Index Contracts** |  |  |  |  |  |
| CME E-mini Health Care Select Sector Index Contracts (United States) | 56 | &nbsp;&nbsp;June 2025 | &nbsp;&nbsp;7978320 | &nbsp;&nbsp;(135701) | &nbsp;&nbsp;&nbsp;&nbsp;(135701) |
| CME E-mini Russell 2000 Index Contracts (United States) | 8 | &nbsp;&nbsp;June 2025 | &nbsp;&nbsp;&nbsp;&nbsp;787920 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(9750) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(9750) |
| Total Equity Index Contracts |  |  |  |  | &nbsp;&nbsp;$(145451) |

---

The notional amount of futures purchased as a percentage of Net Assets is 0.3%

#### Investment Valuation
Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Securities transactions are accounted for as of trade date. The Board of Trustees (the Board) has designated the Fund's investment adviser as the valuation designee responsible for the fair valuation function and performing fair value determinations as needed. The investment adviser has established a Fair Value Committee (the Committee) to carry out the day-to-day fair valuation responsibilities and has adopted policies and procedures to govern the fair valuation process and the activities of the Committee. In accordance with these fair valuation policies and procedures, which have been approved by the Board, the Fund attempts to obtain prices from one or more third party pricing services or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with the policies and procedures. Factors used in determining fair value vary by investment type and may include market or investment specific events, transaction data, estimated cash flows, and market observations of comparable investments. The frequency that the fair valuation procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee manages the Fund's fair valuation practices and maintains the fair valuation policies and procedures. The Fund's investment adviser reports to the Board information regarding the fair valuation process and related material matters.

The inputs to valuation techniques used to value investments are categorized into a disclosure hierarchy consisting of three levels as shown below:

Level 1 – unadjusted quoted prices in active markets for identical investments

Level 2 – other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)

Level 3 – unobservable inputs (including the Fund's own assumptions based on the best information available)

Valuation techniques used to value investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing service on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For any foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.

Futures contracts are valued at the settlement price established each day by the board of trade or exchange on which they are traded and are categorized as Level 1 in the hierarchy. Investments in any open-end mutual funds are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy. If an unaffiliated open-end mutual fund's NAV is unavailable, shares of that fund may be valued by another method that the Board believes reflects fair value in accordance with the Board's fair value pricing policies and is categorized as Level 2 in the hierarchy.

 ***Quarterly Report*** <sub>6</sub>

------

Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy.

#### Derivative Instruments
Risk Exposures and the Use of Derivative Instruments: The Fund's investment objectives allow the Fund to enter into various types of derivative contracts. Derivatives are investments whose value is primarily derived from underlying assets, indices or reference rates and may be transacted on an exchange or over-the-counter (OTC). Derivatives may involve a future commitment to buy or sell a specified asset based on specified terms, to exchange future cash flows at periodic intervals based on a notional principal amount, or for one party to make one or more payments upon the occurrence of specified events in exchange for periodic payments from the other party.

The Fund used derivatives to increase returns, to gain exposure to certain types of assets and/or to manage exposure to certain risks as defined below. The success of any strategy involving derivatives depends on analysis of numerous economic factors, and if the strategies for investment do not work as intended, the Fund may not achieve its objectives.

The Fund's use of derivatives increased or decreased its exposure to the following risk(s):

Equity Risk - Equity risk relates to the fluctuations in the value of financial instruments as a result of changes in market prices (other than those arising from interest rate risk or foreign exchange risk), whether caused by factors specific to an individual investment, its issuer, or all factors affecting all instruments traded in a market or market segment.

Investing in derivatives may involve greater risks than investing in the underlying assets directly and, to varying degrees, may involve risk of loss in excess of any initial investment and collateral received. In addition, there may be the risk that the change in value of the derivative contract does not correspond to the change in value of the underlying instrument.

Futures Contracts: A futures contract is an agreement between two parties to buy or sell a specified underlying instrument for a specified price at a specified future date.

The Fund used futures contracts to manage its exposure to the stock market.

Open futures contracts at period end are presented in the Schedule of Investments under the caption "Futures Contracts". The underlying face amount at value reflects each contract's exposure to the underlying instrument or index at period end. Any securities and/or cash deposited to meet initial margin requirements are identified in the Schedule of Investments.

For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.

---

| | |
|:---|:---|
| **7** | ***Quarterly Report*** |

---

------

*The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.*

*Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.* 

 ***Quarterly Report*** <sub>8</sub>

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** FIDELITY COVINGTON TRUST

- **b. Investment Company Act file number:** 811-07319

- **c. CIK number of Registrant:** 0000945908

- **d. LEI of Registrant:** 549300JFYFTF85QAQR28

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 245 SUMMER STREET

  - **City:** BOSTON

  - **State:** MA

  - **Foreign country:** US

  - **Zip / Postal Code:** 02210

  - **Telephone number:** 1-800-FIDELITY

**Item A.2. Information about the Series.**

- **a. Name of Series:** Fidelity MSCI Health Care Index ETF

- **b. EDGAR series identifier (if any):** S000042575

- **c. LEI of Series:** 549300Y1NOU164X4H550

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-07-31

- **b. Date as of which information is reported:** 2025-04-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $2572211963.74

**Total Liabilities:** $380265.17

**Net Assets:** $2571831698.57

**Cash Not Reported:** $792168.18

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000131667 | 0.45%                | -2.28%               | -3.29%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $1997179.37              | $8168173.75                                |
| Month 2  | $6647729.77              | $-74106970.69                              |
| Month 3  | $19307643.67             | $-111534122.86                             |

### Schedule of Portfolio Investments

| Name                                         | Title                                                      | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Ionis Pharmaceuticals Inc                    | Ionis Pharmaceuticals Inc                                  | CUSIP: 462222100<br>LEI: 549300SI4ZGLG0BLUZ92 | Long             | EC               | CORP              | US        |     61962 | NS      | $1902853.02   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| MiMedx Group Inc                             | MiMedx Group Inc                                           | CUSIP: 602496101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     50452 | NS      | $347109.76    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Ligand Pharmaceuticals Inc                   | Ligand Pharmaceuticals Inc                                 | CUSIP: 53220K504<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |      8327 | NS      | $914804.22    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| US Physical Therapy Inc                      | US Physical Therapy Inc                                    | CUSIP: 90337L108<br>LEI: 529900KL1UXQYFIOMY96 | Long             | EC               | CORP              | US        |      6601 | NS      | $469397.11    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Charles River Laboratories International Inc | Charles River Laboratories International Inc               | CUSIP: 159864107<br>LEI: 549300BSQ0R4UZ5KX287 | Long             | EC               | CORP              | US        |     22355 | NS      | $2651750.10   | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| 10X Genomics Inc                             | 10X Genomics Inc                                           | CUSIP: 88025U109<br>LEI: 5493003Z6741WNLG7H43 | Long             | EC               | CORP              | US        |     41440 | NS      | $342708.80    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Neogen Corp                                  | Neogen Corp                                                | CUSIP: 640491106<br>LEI: 549300HJT9FC36N4UW43 | Long             | EC               | CORP              | US        |     89680 | NS      | $452884.00    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Pliant Therapeutics Inc                      | Pliant Therapeutics Inc                                    | CUSIP: 729139105<br>LEI: 5493002Q5LITR7VHZH02 | Long             | EC               | CORP              | US        |     21625 | NS      | $34383.75     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Arrowhead Pharmaceuticals Inc                | Arrowhead Pharmaceuticals Inc                              | CUSIP: 04280A100<br>LEI: 549300O3CSB8T7OZ3D66 | Long             | EC               | CORP              | US        |     48843 | NS      | $678429.27    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| DENTSPLY SIRONA Inc                          | DENTSPLY SIRONA Inc                                        | CUSIP: 24906P109<br>LEI: 9NHEHR1SOZCYXDO8HO28 | Long             | EC               | CORP              | US        |     86806 | NS      | $1206603.40   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Protagonist Therapeutics Inc                 | Protagonist Therapeutics Inc                               | CUSIP: 74366E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     19836 | NS      | $908885.52    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Amedisys Inc                                 | Amedisys Inc                                               | CUSIP: 023436108<br>LEI: 5299001RBS9GK9STN379 | Long             | EC               | CORP              | US        |     14273 | NS      | $1354507.70   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Rhythm Pharmaceuticals Inc                   | Rhythm Pharmaceuticals Inc                                 | CUSIP: 76243J105<br>LEI: 529900JPNWXQ8DPLA551 | Long             | EC               | CORP              | US        |     20193 | NS      | $1316381.67   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Evolent Health Inc                           | Evolent Health Inc                                         | CUSIP: 30050B101<br>LEI: 549300CZOCFHQ2BBTR11 | Long             | EC               | CORP              | US        |     43218 | NS      | $426129.48    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Alnylam Pharmaceuticals Inc                  | Alnylam Pharmaceuticals Inc                                | CUSIP: 02043Q107<br>LEI: 529900S3ZI14OWRJII50 | Long             | EC               | CORP              | US        |     56542 | NS      | $14884116.08  | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Waystar Holding Corp                         | Waystar Holding Corp                                       | CUSIP: 946784105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     30154 | NS      | $1120824.18   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Anavex Life Sciences Corp                    | Anavex Life Sciences Corp                                  | CUSIP: 032797300<br>LEI: 549300K1I5L8COCQ8W36 | Long             | EC               | CORP              | US        |     37156 | NS      | $352982.00    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Vera Therapeutics Inc                        | Vera Therapeutics Inc                                      | CUSIP: 92337R101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     20060 | NS      | $468802.20    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| AMN Healthcare Services Inc                  | AMN Healthcare Services Inc                                | CUSIP: 001744101<br>LEI: 529900W3ARRTCNFH2I39 | Long             | EC               | CORP              | US        |     16465 | NS      | $336379.95    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Viatris Inc                                  | Viatris Inc                                                | CUSIP: 92556V106<br>LEI: 254900ZZTSW7NL773X71 | Long             | EC               | CORP              | US        |    522026 | NS      | $4395458.92   | 0.17%             |  |  |  | No            |                  1 | On Loan: No      |
| Relay Therapeutics Inc                       | Relay Therapeutics Inc                                     | CUSIP: 75943R102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     50830 | NS      | $169263.90    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Simulations Plus Inc                         | Simulations Plus Inc                                       | CUSIP: 829214105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7329 | NS      | $251751.15    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Entrada Therapeutics Inc                     | Entrada Therapeutics Inc                                   | CUSIP: 29384C108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7990 | NS      | $72948.70     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Newamsterdam Pharma Co NV                    | Newamsterdam Pharma Co NV                                  | CUSIP: 000000000<br>LEI: 984500B6549TF6E14D36 | Long             | EC               | CORP              | NL        |     15969 | NS      | $305486.97    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Kura Oncology Inc                            | Kura Oncology Inc                                          | CUSIP: 50127T109<br>LEI: 5493005QORQTZCZYOP39 | Long             | EC               | CORP              | US        |     19953 | NS      | $130891.68    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Vertex Pharmaceuticals Inc                   | Vertex Pharmaceuticals Inc                                 | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |    112905 | NS      | $57525097.50  | 2.24%             |  |  |  | No            |                  1 | On Loan: No      |
| SI-BONE Inc                                  | SI-BONE Inc                                                | CUSIP: 825704109<br>LEI: 549300J8JGYVJJHV9C31 | Long             | EC               | CORP              | US        |     16569 | NS      | $226166.85    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                            | Johnson & Johnson                                          | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |   1055545 | NS      | $164992238.95 | 6.42%             |  |  |  | No            |                  1 | On Loan: No      |
| BioCryst Pharmaceuticals Inc                 | BioCryst Pharmaceuticals Inc                               | CUSIP: 09058V103<br>LEI: 549300Z0INP1Z5NP6J59 | Long             | EC               | CORP              | US        |     85820 | NS      | $759507.00    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group Inc                       | UnitedHealth Group Inc                                     | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |    403468 | NS      | $166002873.92 | 6.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Exact Sciences Corp                          | Exact Sciences Corp                                        | CUSIP: 30063P105<br>LEI: 549300VM3X1FYD4N9Z14 | Long             | EC               | CORP              | US        |     81208 | NS      | $3706333.12   | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Omnicell Inc                                 | Omnicell Inc                                               | CUSIP: 68213N109<br>LEI: 5493008RH0GTKHHPZI77 | Long             | EC               | CORP              | US        |     20343 | NS      | $635922.18    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Prestige Consumer Healthcare Inc             | Prestige Consumer Healthcare Inc                           | CUSIP: 74112D101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     21681 | NS      | $1761147.63   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Verve Therapeutics Inc                       | Verve Therapeutics Inc                                     | CUSIP: 92539P101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     26887 | NS      | $152449.29    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| BrightSpring Health Services Inc             | BrightSpring Health Services Inc                           | CUSIP: 10950A106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     26184 | NS      | $459005.52    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Mind Medicine MindMed Inc                    | Mind Medicine MindMed Inc                                  | CUSIP: 60255C885<br>LEI: 549300QY8KN1O6RPFJ13 | Long             | EC               | CORP              | CA        |     23776 | NS      | $151928.64    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Repligen Corp                                | Repligen Corp                                              | CUSIP: 759916109<br>LEI: 54930006QJ0T5AUO1E71 | Long             | EC               | CORP              | US        |     23341 | NS      | $3220824.59   | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| BioLife Solutions Inc                        | BioLife Solutions Inc                                      | CUSIP: 09062W204<br>LEI: 549300G2IVCMC2TJDW72 | Long             | EC               | CORP              | US        |     16473 | NS      | $397164.03    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Revvity Inc                                  | Revvity Inc                                                | CUSIP: 714046109<br>LEI: 549300IKL1SDPFI7N655 | Long             | EC               | CORP              | US        |     53337 | NS      | $4983275.91   | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Septerna Inc                                 | Septerna Inc                                               | CUSIP: 81734D104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6803 | NS      | $47348.88     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Pacira BioSciences Inc                       | Pacira BioSciences Inc                                     | CUSIP: 695127100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     19895 | NS      | $535175.50    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Merus NV                                     | Merus NV                                                   | CUSIP: 000000000<br>LEI: 549300W8GPUWU8QNU293 | Long             | EC               | CORP              | NL        |     20841 | NS      | $948473.91    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Catalyst Pharmaceuticals Inc                 | Catalyst Pharmaceuticals Inc                               | CUSIP: 14888U101<br>LEI: 5299004O0R5XXLA5H544 | Long             | EC               | CORP              | US        |     47349 | NS      | $1150107.21   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Brookdale Senior Living Inc                  | Brookdale Senior Living Inc                                | CUSIP: 112463104<br>LEI: LH7MQB13NWY7CJ9VC445 | Long             | EC               | CORP              | US        |     81405 | NS      | $534016.80    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| UFP Technologies Inc                         | UFP Technologies Inc                                       | CUSIP: 902673102<br>LEI: 549300RJ8LY41HS70C91 | Long             | EC               | CORP              | US        |      3360 | NS      | $700694.40    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| AbbVie Inc                                   | AbbVie Inc                                                 | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |    774740 | NS      | $151151774.00 | 5.88%             |  |  |  | No            |                  1 | On Loan: No      |
| Zymeworks Inc                                | Zymeworks Inc                                              | CUSIP: 98985Y108<br>LEI: 894500AHOYAGYLYZJL67 | Long             | EC               | CORP              | US        |     18114 | NS      | $235663.14    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| agilon health Inc                            | agilon health Inc                                          | CUSIP: 00857U107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    138767 | NS      | $591147.42    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| AtriCure Inc                                 | AtriCure Inc                                               | CUSIP: 04963C209<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     21418 | NS      | $640612.38    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Universal Health Services Inc                | Universal Health Services Inc                              | CUSIP: 913903100<br>LEI: 549300YGMGQDO0NMJD09 | Long             | EC               | CORP              | US        |     25727 | NS      | $4555479.89   | 0.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Immunome Inc                                 | Immunome Inc                                               | CUSIP: 45257U108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     28546 | NS      | $250919.34    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Myriad Genetics Inc                          | Myriad Genetics Inc                                        | CUSIP: 62855J104<br>LEI: 52990044IHUOUMETT163 | Long             | EC               | CORP              | US        |     39640 | NS      | $293732.40    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Thermo Fisher Scientific Inc                 | Thermo Fisher Scientific Inc                               | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |    167698 | NS      | $71942442.00  | 2.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Dyne Therapeutics Inc                        | Dyne Therapeutics Inc                                      | CUSIP: 26818M108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     26763 | NS      | $315535.77    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Axogen Inc                                   | Axogen Inc                                                 | CUSIP: 05463X106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     18307 | NS      | $297854.89    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Mesa Laboratories Inc                        | Mesa Laboratories Inc                                      | CUSIP: 59064R109<br>LEI: 549300ZCG738WLX8ZW79 | Long             | EC               | CORP              | US        |      2437 | NS      | $280864.25    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| CONTRA CHINOOK THERAPE                       | CONTRA CHINOOK THERAPE                                     | CUSIP: 169CVR016<br>LEI: 549300X0O3003W5QYQ48 | Long             | EC               | CORP              | US        |     24218 | NS      | $0.24         | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Pacific Biosciences of California Inc        | Pacific Biosciences of California Inc                      | CUSIP: 69404D108<br>LEI: 529900F1BWRE1M0KZN89 | Long             | EC               | CORP              | US        |    103826 | NS      | $115246.86    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Phathom Pharmaceuticals Inc                  | Phathom Pharmaceuticals Inc                                | CUSIP: 71722W107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     16406 | NS      | $70381.74     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Teladoc Health Inc                           | Teladoc Health Inc                                         | CUSIP: 87918A105<br>LEI: 549300I2PVFBC9MFAC61 | Long             | EC               | CORP              | US        |     74394 | NS      | $534892.86    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| GRAIL Inc                                    | GRAIL Inc                                                  | CUSIP: 384747101<br>LEI: 2549009XSNESW3VE8024 | Long             | EC               | CORP              | US        |     13251 | NS      | $457093.25    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Agilent Technologies Inc                     | Agilent Technologies Inc                                   | CUSIP: 00846U101<br>LEI: QUIX8Y7A2WP0XRMW7G29 | Long             | EC               | CORP              | US        |    125207 | NS      | $13472273.20  | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| BioMarin Pharmaceutical Inc                  | BioMarin Pharmaceutical Inc                                | CUSIP: 09061G101<br>LEI: NSLL8ITTRR0J5HEMR848 | Long             | EC               | CORP              | US        |     83418 | NS      | $5312892.42   | 0.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Geron Corp                                   | Geron Corp                                                 | CUSIP: 374163103<br>LEI: 549300T282D7Z2YESL90 | Long             | EC               | CORP              | US        |    223722 | NS      | $315448.02    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Viridian Therapeutics Inc                    | Viridian Therapeutics Inc                                  | CUSIP: 92790C104<br>LEI: 549300C775BNYF550E70 | Long             | EC               | CORP              | US        |     23647 | NS      | $320416.85    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Merit Medical Systems Inc                    | Merit Medical Systems Inc                                  | CUSIP: 589889104<br>LEI: 549300OYTY138SP2CE83 | Long             | EC               | CORP              | US        |     25590 | NS      | $2416975.50   | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Chicago Mercantile Exchange                  | E-MINI RUSS 2000 JUN25                                     | CUSIP: 000000000<br>LEI: SNZ2OJLFK8MNNCLQOF39 | N/A              | DE               |  | US        |         8 | NC      | $-9750.03     | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| Alignment Healthcare Inc                     | Alignment Healthcare Inc                                   | CUSIP: 01625V104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     42402 | NS      | $751363.44    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Harrow Inc                                   | Harrow Inc                                                 | CUSIP: 415858109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     13137 | NS      | $325403.49    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Spyre Therapeutics Inc                       | Spyre Therapeutics Inc                                     | CUSIP: 00773J202<br>LEI: 52990017AIJPRH3HQH40 | Long             | EC               | CORP              | US        |     15233 | NS      | $231998.59    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| iRhythm Technologies Inc                     | iRhythm Technologies Inc                                   | CUSIP: 450056106<br>LEI: 549300FJI72RJGDQS384 | Long             | EC               | CORP              | US        |     13631 | NS      | $1457017.59   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| LifeStance Health Group Inc                  | LifeStance Health Group Inc                                | CUSIP: 53228F101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     58499 | NS      | $384338.43    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Tandem Diabetes Care Inc                     | Tandem Diabetes Care Inc                                   | CUSIP: 875372203<br>LEI: 549300JEPFOD0K4D3I05 | Long             | EC               | CORP              | US        |     28883 | NS      | $486678.55    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Definitive Healthcare Corp                   | Definitive Healthcare Corp                                 | CUSIP: 24477E103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     22128 | NS      | $60188.16     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Cooper Cos Inc/The                           | Cooper Cos Inc/The                                         | CUSIP: 216648501<br>LEI: QJKMVPIGLH7530PCUE20 | Long             | EC               | CORP              | US        |     87505 | NS      | $7146533.35   | 0.28%             |  |  |  | No            |                  1 | On Loan: No      |
| OMNIAB INC                                   | OMNIAB INC                                                 | CUSIP: 68218J301<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3335 | NS      | $6369.85      | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Beam Therapeutics Inc                        | Beam Therapeutics Inc                                      | CUSIP: 07373V105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     39023 | NS      | $777728.39    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Tourmaline Bio Inc                           | Tourmaline Bio Inc                                         | CUSIP: 89157D105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4471 | NS      | $76945.91     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Select Medical Holdings Corp                 | Select Medical Holdings Corp                               | CUSIP: 81619Q105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     48591 | NS      | $886299.84    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| DaVita Inc                                   | DaVita Inc                                                 | CUSIP: 23918K108<br>LEI: M2XHYMU3TZNEZURC6H66 | Long             | EC               | CORP              | US        |     19770 | NS      | $2798443.50   | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Adaptive Biotechnologies Corp                | Adaptive Biotechnologies Corp                              | CUSIP: 00650F109<br>LEI: 549300ZTF7OT1FW66Q96 | Long             | EC               | CORP              | US        |     45069 | NS      | $331707.84    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| GoodRx Holdings Inc                          | GoodRx Holdings Inc                                        | CUSIP: 38246G108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     40181 | NS      | $186038.03    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Travere Therapeutics Inc                     | Travere Therapeutics Inc                                   | CUSIP: 89422G107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     35738 | NS      | $743707.78    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Scilex Holding Co                            | Scilex Holding Co                                          | CUSIP: 80880W205<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       998 | NS      | $4729.24      | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Erasca Inc                                   | Erasca Inc                                                 | CUSIP: 29479A108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     84048 | NS      | $122710.08    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Bruker Corp                                  | Bruker Corp                                                | CUSIP: 116794108<br>LEI: LEBZ6VLQ6I8XB1NHVY15 | Long             | EC               | CORP              | US        |     46346 | NS      | $1856620.76   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Collegium Pharmaceutical Inc                 | Collegium Pharmaceutical Inc                               | CUSIP: 19459J104<br>LEI: 54930049FXZMTLW8D496 | Long             | EC               | CORP              | US        |     14107 | NS      | $380818.47    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Supernus Pharmaceuticals Inc                 | Supernus Pharmaceuticals Inc                               | CUSIP: 868459108<br>LEI: 549300GRM36VBKISYJ58 | Long             | EC               | CORP              | US        |     24180 | NS      | $785366.40    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| AnaptysBio Inc                               | AnaptysBio Inc                                             | CUSIP: 032724106<br>LEI: 529900HH4WQT03IG1A12 | Long             | EC               | CORP              | US        |      7549 | NS      | $167738.78    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Novocure Ltd                                 | Novocure Ltd                                               | CUSIP: 000000000<br>LEI: 213800YPP55UMHWA4826 | Long             | EC               | CORP              | JE        |     44906 | NS      | $814594.84    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| CorMedix Inc                                 | CorMedix Inc                                               | CUSIP: 21900C308<br>LEI: 5299006YIA3L0MBW8358 | Long             | EC               | CORP              | US        |     26590 | NS      | $244362.10    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Medtronic PLC                                | Medtronic PLC                                              | CUSIP: 000000000<br>LEI: 549300GX3ZBSQWUXY261 | Long             | EC               | CORP              | IE        |    562173 | NS      | $47649783.48  | 1.85%             |  |  |  | No            |                  1 | On Loan: No      |
| Agios Pharmaceuticals Inc                    | Agios Pharmaceuticals Inc                                  | CUSIP: 00847X104<br>LEI: 529900ONJHY8EOGYT555 | Long             | EC               | CORP              | US        |     22514 | NS      | $668440.66    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Centene Corp                                 | Centene Corp                                               | CUSIP: 15135B101<br>LEI: 549300Z7JJ4TQSQGT333 | Long             | EC               | CORP              | US        |    221344 | NS      | $13247438.40  | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Premier Inc                                  | Premier Inc                                                | CUSIP: 74051N102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     42113 | NS      | $856999.55    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcturus Therapeutics Holdings Inc           | Arcturus Therapeutics Holdings Inc                         | CUSIP: 03969T109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     10419 | NS      | $133467.39    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Intellia Therapeutics Inc                    | Intellia Therapeutics Inc                                  | CUSIP: 45826J105<br>LEI: 5493002T5BCPE5DZC723 | Long             | EC               | CORP              | US        |     42137 | NS      | $373755.19    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Zoetis Inc                                   | Zoetis Inc                                                 | CUSIP: 98978V103<br>LEI: 549300HD9Q1LOC9KLJ48 | Long             | EC               | CORP              | US        |    197798 | NS      | $30935607.20  | 1.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Halozyme Therapeutics Inc                    | Halozyme Therapeutics Inc                                  | CUSIP: 40637H109<br>LEI: 529900242I3SV9AGM753 | Long             | EC               | CORP              | US        |     55654 | NS      | $3418268.68   | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Boston Scientific Corp                       | Boston Scientific Corp                                     | CUSIP: 101137107<br>LEI: Y6ZDD9FP4P8JSSJMW954 | Long             | EC               | CORP              | US        |    646158 | NS      | $66470273.46  | 2.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Zimmer Biomet Holdings Inc                   | Zimmer Biomet Holdings Inc                                 | CUSIP: 98956P102<br>LEI: 2P2YLDVPES3BXQ1FRB91 | Long             | EC               | CORP              | US        |     87278 | NS      | $8993997.90   | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| CONMED Corp                                  | CONMED Corp                                                | CUSIP: 207410101<br>LEI: Z6C0YCECH9DCU5ZIQW84 | Long             | EC               | CORP              | US        |     13793 | NS      | $677374.23    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| ResMed Inc                                   | ResMed Inc                                                 | CUSIP: 761152107<br>LEI: 529900T3QE5253CCXF22 | Long             | EC               | CORP              | US        |     64353 | NS      | $15225276.27  | 0.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Elevance Health Inc                          | Elevance Health Inc                                        | CUSIP: 036752103<br>LEI: 8MYN82XMYQH89CTMTH67 | Long             | EC               | CORP              | US        |    101672 | NS      | $42761209.76  | 1.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Pediatrix Medical Group Inc                  | Pediatrix Medical Group Inc                                | CUSIP: 58502B106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     37871 | NS      | $487778.48    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Apellis Pharmaceuticals Inc                  | Apellis Pharmaceuticals Inc                                | CUSIP: 03753U106<br>LEI: 254900HS0ZFRXXSB9D42 | Long             | EC               | CORP              | US        |     29990 | NS      | $576107.90    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Biogen Inc                                   | Biogen Inc                                                 | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |     63886 | NS      | $7735316.88   | 0.30%             |  |  |  | No            |                  1 | On Loan: No      |
| RxSight Inc                                  | RxSight Inc                                                | CUSIP: 78349D107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     15378 | NS      | $226364.16    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Madrigal Pharmaceuticals Inc                 | Madrigal Pharmaceuticals Inc                               | CUSIP: 558868105<br>LEI: 549300CHIMT2EUSNJB60 | Long             | EC               | CORP              | US        |      5781 | NS      | $1930333.71   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Inspire Medical Systems Inc                  | Inspire Medical Systems Inc                                | CUSIP: 457730109<br>LEI: 549300XQQCQ7HCJKTW25 | Long             | EC               | CORP              | US        |     13111 | NS      | $2076520.18   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| EyePoint Pharmaceuticals Inc                 | EyePoint Pharmaceuticals Inc                               | CUSIP: 30233G209<br>LEI: 549300QE1RU34T50MR69 | Long             | EC               | CORP              | US        |     26794 | NS      | $182735.08    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Ceribell Inc                                 | Ceribell Inc                                               | CUSIP: 15678C102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5495 | NS      | $88414.55     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| AdaptHealth Corp                             | AdaptHealth Corp                                           | CUSIP: 00653Q102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     37816 | NS      | $321814.16    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Arbutus Biopharma Corp                       | Arbutus Biopharma Corp                                     | CUSIP: 03879J100<br>LEI: 25490064CESONAUIAS23 | Long             | EC               | CORP              | CA        |     61909 | NS      | $219776.95    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Ironwood Pharmaceuticals Inc                 | Ironwood Pharmaceuticals Inc                               | CUSIP: 46333X108<br>LEI: 549300PC8MR6QHH6P296 | Long             | EC               | CORP              | US        |     61930 | NS      | $57737.34     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| United Therapeutics Corp                     | United Therapeutics Corp                                   | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |     18580 | NS      | $5631412.20   | 0.22%             |  |  |  | No            |                  1 | On Loan: No      |
| ACADIA Pharmaceuticals Inc                   | ACADIA Pharmaceuticals Inc                                 | CUSIP: 004225108<br>LEI: 529900O3044NO0PEA039 | Long             | EC               | CORP              | US        |     47759 | NS      | $697281.40    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Cullinan Therapeutics Inc                    | Cullinan Therapeutics Inc                                  | CUSIP: 230031106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     13919 | NS      | $115249.32    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Addus HomeCare Corp                          | Addus HomeCare Corp                                        | CUSIP: 006739106<br>LEI: 52990090ZT33AKPDBX62 | Long             | EC               | CORP              | US        |      7923 | NS      | $828349.65    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Insulet Corp                                 | Insulet Corp                                               | CUSIP: 45784P101<br>LEI: 549300TZTYD2PYN92D43 | Long             | EC               | CORP              | US        |     30770 | NS      | $7762963.30   | 0.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Align Technology Inc                         | Align Technology Inc                                       | CUSIP: 016255101<br>LEI: 549300N5YSE0U3LCP840 | Long             | EC               | CORP              | US        |     31151 | NS      | $5398468.30   | 0.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Viking Therapeutics Inc                      | Viking Therapeutics Inc                                    | CUSIP: 92686J106<br>LEI: 529900IVC72YPFA25M37 | Long             | EC               | CORP              | US        |     44339 | NS      | $1280066.93   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Becton Dickinson & Co                        | Becton Dickinson & Co                                      | CUSIP: 075887109<br>LEI: ICE2EP6D98PQUILVRZ91 | Long             | EC               | CORP              | US        |    127147 | NS      | $26330872.23  | 1.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Penumbra Inc                                 | Penumbra Inc                                               | CUSIP: 70975L107<br>LEI: 549300RGE06P3ECANU72 | Long             | EC               | CORP              | US        |     16060 | NS      | $4703010.40   | 0.18%             |  |  |  | No            |                  1 | On Loan: No      |
| ANI Pharmaceuticals Inc                      | ANI Pharmaceuticals Inc                                    | CUSIP: 00182C103<br>LEI: 5493000T6CXTND40YH31 | Long             | EC               | CORP              | US        |      7517 | NS      | $532353.94    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Revolution Medicines Inc                     | Revolution Medicines Inc                                   | CUSIP: 76155X100<br>LEI: 549300JU3X0LBCQ65892 | Long             | EC               | CORP              | US        |     62563 | NS      | $2526293.94   | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| IQVIA Holdings Inc                           | IQVIA Holdings Inc                                         | CUSIP: 46266C105<br>LEI: 549300W3R20NM4KQPH86 | Long             | EC               | CORP              | US        |     79575 | NS      | $12339695.25  | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Veeva Systems Inc                            | Veeva Systems Inc                                          | CUSIP: 922475108<br>LEI: 549300YZEXPDB92M2F02 | Long             | EC               | CORP              | US        |     67616 | NS      | $15801183.04  | 0.61%             |  |  |  | No            |                  1 | On Loan: No      |
| OrthoPediatrics Corp                         | OrthoPediatrics Corp                                       | CUSIP: 68752L100<br>LEI: 5493000KUTPFGOPAT717 | Long             | EC               | CORP              | US        |      7399 | NS      | $154047.18    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Moderna Inc                                  | Moderna Inc                                                | CUSIP: 60770K107<br>LEI: 549300EI6OKH5K5Q2G38 | Long             | EC               | CORP              | US        |    143764 | NS      | $4103024.56   | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Biohaven Ltd                                 | Biohaven Ltd                                               | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | VG        |     37671 | NS      | $833282.52    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Stryker Corp                                 | Stryker Corp                                               | CUSIP: 863667101<br>LEI: 5493002F0SC4JTBU5137 | Long             | EC               | CORP              | US        |    150420 | NS      | $56245046.40  | 2.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Iovance Biotherapeutics Inc                  | Iovance Biotherapeutics Inc                                | CUSIP: 462260100<br>LEI: 2549002L8WT2ACU5Q878 | Long             | EC               | CORP              | US        |     92768 | NS      | $333037.12    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| ORIC Pharmaceuticals Inc                     | ORIC Pharmaceuticals Inc                                   | CUSIP: 68622P109<br>LEI: 54930033FJRNEYBW0L25 | Long             | EC               | CORP              | US        |     14660 | NS      | $83708.60     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Chicago Mercantile Exchange                  | XAV HEALTH CARE JUN25                                      | CUSIP: 000000000<br>LEI: SNZ2OJLFK8MNNCLQOF39 | N/A              | DE               |  | US        |        56 | NC      | $-135701.24   | -0.01%            |  |  |  | No            |                  1 | On Loan: No      |
| Amphastar Pharmaceuticals Inc                | Amphastar Pharmaceuticals Inc                              | CUSIP: 03209R103<br>LEI: 54930055TH0ZLSAQMJ38 | Long             | EC               | CORP              | US        |     16856 | NS      | $411454.96    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Tilray Brands Inc                            | Tilray Brands Inc                                          | CUSIP: 88688T100<br>LEI: 549300Y4V60733TO1478 | Long             | EC               | CORP              | US        |    409080 | NS      | $198444.71    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Alphatec Holdings Inc                        | Alphatec Holdings Inc                                      | CUSIP: 02081G201<br>LEI: 549300EZE8CQ8K65FS24 | Long             | EC               | CORP              | US        |     45853 | NS      | $503465.94    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| STAAR Surgical Co                            | STAAR Surgical Co                                          | CUSIP: 852312305<br>LEI: 5299006LRHI7OJ8BY308 | Long             | EC               | CORP              | US        |     16748 | NS      | $305818.48    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Avanos Medical Inc                           | Avanos Medical Inc                                         | CUSIP: 05350V106<br>LEI: 549300YCXWOM7NEWMQ58 | Long             | EC               | CORP              | US        |     20107 | NS      | $252342.85    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Recursion Pharmaceuticals Inc                | Recursion Pharmaceuticals Inc                              | CUSIP: 75629V104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    108041 | NS      | $603949.19    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Celldex Therapeutics Inc                     | Celldex Therapeutics Inc                                   | CUSIP: 15117B202<br>LEI: 529900F018DMYWH38923 | Long             | EC               | CORP              | US        |     26092 | NS      | $543496.36    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Amneal Pharmaceuticals Inc                   | Amneal Pharmaceuticals Inc                                 | CUSIP: 03168L105<br>LEI: 549300VV176ZO5WQHZ61 | Long             | EC               | CORP              | US        |     60822 | NS      | $465896.52    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Cigna Group/The                              | Cigna Group/The                                            | CUSIP: 125523100<br>LEI: 549300VIWYMSIGT1U456 | Long             | EC               | CORP              | US        |    121941 | NS      | $41464817.64  | 1.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Establishment Labs Holdings Inc              | Establishment Labs Holdings Inc                            | CUSIP: 000000000<br>LEI: 549300BCBQ714JNJ7V58 | Long             | EC               | CORP              | VG        |      8985 | NS      | $272694.75    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Integra LifeSciences Holdings Corp           | Integra LifeSciences Holdings Corp                         | CUSIP: 457985208<br>LEI: WB7IJCYY8YFTENS4O147 | Long             | EC               | CORP              | US        |     30431 | NS      | $498764.09    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Twist Bioscience Corp                        | Twist Bioscience Corp                                      | CUSIP: 90184D100<br>LEI: 549300T23BL59LCOH584 | Long             | EC               | CORP              | US        |     25839 | NS      | $990150.48    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| CRISPR Therapeutics AG                       | CRISPR Therapeutics AG                                     | CUSIP: 000000000<br>LEI: 506700O6IRRIQLT3W370 | Long             | EC               | CORP              | CH        |     35766 | NS      | $1383071.22   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Disc Medicine Inc                            | Disc Medicine Inc                                          | CUSIP: 254604101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      8084 | NS      | $399511.28    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| CVS Health Corp                              | CVS Health Corp                                            | CUSIP: 126650100<br>LEI: 549300EJG376EN5NQE29 | Long             | EC               | CORP              | US        |    551711 | NS      | $36804640.81  | 1.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Denali Therapeutics Inc                      | Denali Therapeutics Inc                                    | CUSIP: 24823R105<br>LEI: 549300ZTQ2HO18L3Q830 | Long             | EC               | CORP              | US        |     56110 | NS      | $934231.50    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Illumina Inc                                 | Illumina Inc                                               | CUSIP: 452327109<br>LEI: SQ95QG8SR5Q56LSNF682 | Long             | EC               | CORP              | US        |     69720 | NS      | $5410272.00   | 0.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Doximity Inc                                 | Doximity Inc                                               | CUSIP: 26622P107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     47729 | NS      | $2714825.52   | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Cytek Biosciences Inc                        | Cytek Biosciences Inc                                      | CUSIP: 23285D109<br>LEI: 549300K2J28BOC6FBO89 | Long             | EC               | CORP              | US        |     50418 | NS      | $187050.78    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| LivaNova PLC                                 | LivaNova PLC                                               | CUSIP: 000000000<br>LEI: 2138001K2FX6SHK2B339 | Long             | EC               | CORP              | GB        |     23670 | NS      | $875790.00    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Sana Biotechnology Inc                       | Sana Biotechnology Inc                                     | CUSIP: 799566104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     51005 | NS      | $96909.50     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| MoonLake Immunotherapeutics                  | MoonLake Immunotherapeutics                                | CUSIP: 61559X104<br>LEI: N/A                  | Long             | EC               | CORP              | KY        |      9648 | NS      | $405987.84    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Akero Therapeutics Inc                       | Akero Therapeutics Inc                                     | CUSIP: 00973Y108<br>LEI: 549300SI3KG74LBE2955 | Long             | EC               | CORP              | US        |     21174 | NS      | $965746.14    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| TransMedics Group Inc                        | TransMedics Group Inc                                      | CUSIP: 89377M109<br>LEI: 549300060GVOSMWARH50 | Long             | EC               | CORP              | US        |     14660 | NS      | $1348866.60   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Cargo Therapeutics Inc                       | Cargo Therapeutics Inc                                     | CUSIP: 14179K101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      8026 | NS      | $36678.82     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Tarsus Pharmaceuticals Inc                   | Tarsus Pharmaceuticals Inc                                 | CUSIP: 87650L103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     12565 | NS      | $652249.15    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Guardant Health Inc                          | Guardant Health Inc                                        | CUSIP: 40131M109<br>LEI: 254900M8C3E5VC8BR186 | Long             | EC               | CORP              | US        |     54511 | NS      | $2574554.53   | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Avadel Pharmaceuticals PLC                   | Avadel Pharmaceuticals PLC                                 | CUSIP: 000000000<br>LEI: 549300E27PTSG2RHC762 | Long             | EC               | CORP              | IE        |     37818 | NS      | $336202.02    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Axsome Therapeutics Inc                      | Axsome Therapeutics Inc                                    | CUSIP: 05464T104<br>LEI: 549300EXGR0XLRJEIB95 | Long             | EC               | CORP              | US        |     13833 | NS      | $1553307.57   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| WaVe Life Sciences Ltd                       | WaVe Life Sciences Ltd                                     | CUSIP: 000000000<br>LEI: 54930070006GPKFYZ813 | Long             | EC               | CORP              | SG        |     43433 | NS      | $335302.76    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| ImmunityBio Inc                              | ImmunityBio Inc                                            | CUSIP: 45256X103<br>LEI: 529900J9XLBR4HFL4B83 | Long             | EC               | CORP              | US        |     92823 | NS      | $232985.73    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Perrigo Co PLC                               | Perrigo Co PLC                                             | CUSIP: 000000000<br>LEI: 549300IFOQS6R1QLY196 | Long             | EC               | CORP              | IE        |     60280 | NS      | $1550401.60   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Incyte Corp                                  | Incyte Corp                                                | CUSIP: 45337C102<br>LEI: 549300Z4WN6JVZ3T4680 | Long             | EC               | CORP              | US        |     71991 | NS      | $4510956.06   | 0.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvation Bio Inc                             | Nuvation Bio Inc                                           | CUSIP: 67080N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     94718 | NS      | $213115.50    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| GeneDx Holdings Corp                         | GeneDx Holdings Corp                                       | CUSIP: 81663L200<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7229 | NS      | $483258.65    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Krystal Biotech Inc                          | Krystal Biotech Inc                                        | CUSIP: 501147102<br>LEI: 549300YONUY68210OE41 | Long             | EC               | CORP              | US        |      9410 | NS      | $1598570.80   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| CONTRA AKOUOS INC                            | CONTRA AKOUOS INC                                          | CUSIP: 009CVR036<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     11863 | NS      | $2135.34      | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Globus Medical Inc                           | Globus Medical Inc                                         | CUSIP: 379577208<br>LEI: 5299003M2P4CIK0RF205 | Long             | EC               | CORP              | US        |     49877 | NS      | $3579672.29   | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Pennant Group Inc/The                        | Pennant Group Inc/The                                      | CUSIP: 70805E109<br>LEI: 5493007H2OYR6BYLDA64 | Long             | EC               | CORP              | US        |     15646 | NS      | $400850.52    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| ADMA Biologics Inc                           | ADMA Biologics Inc                                         | CUSIP: 000899104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    103577 | NS      | $2465132.60   | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Intuitive Surgical Inc                       | Intuitive Surgical Inc                                     | CUSIP: 46120E602<br>LEI: 54930052SRG011710797 | Long             | EC               | CORP              | US        |    156161 | NS      | $80547843.80  | 3.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Hims & Hers Health Inc                       | Hims & Hers Health Inc                                     | CUSIP: 433000106<br>LEI: 549300ZQ4ZUYSAAX6P59 | Long             | EC               | CORP              | US        |     78261 | NS      | $2590439.10   | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| ArriVent Biopharma Inc                       | ArriVent Biopharma Inc                                     | CUSIP: 04272N102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5852 | NS      | $124413.52    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Amgen Inc                                    | Amgen Inc                                                  | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |    235658 | NS      | $68557625.36  | 2.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Ideaya Biosciences Inc                       | Ideaya Biosciences Inc                                     | CUSIP: 45166A102<br>LEI: 549300ULW08F62IJML11 | Long             | EC               | CORP              | US        |     34509 | NS      | $694666.17    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Butterfly Network Inc                        | Butterfly Network Inc                                      | CUSIP: 124155102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     61325 | NS      | $143500.50    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Avidity Biosciences Inc                      | Avidity Biosciences Inc                                    | CUSIP: 05370A108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     36593 | NS      | $1194761.45   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Replimune Group Inc                          | Replimune Group Inc                                        | CUSIP: 76029N106<br>LEI: 549300AY704NEIRC4K64 | Long             | EC               | CORP              | US        |     22989 | NS      | $224832.42    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| National HealthCare Corp                     | National HealthCare Corp                                   | CUSIP: 635906100<br>LEI: 254900PTS11LS1JS2752 | Long             | EC               | CORP              | US        |      5760 | NS      | $544262.40    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Medpace Holdings Inc                         | Medpace Holdings Inc                                       | CUSIP: 58506Q109<br>LEI: 549300H8TYEUVTW14A54 | Long             | EC               | CORP              | US        |     11611 | NS      | $3580716.29   | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Labcorp Holdings Inc                         | Labcorp Holdings Inc                                       | CUSIP: 504922105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     36670 | NS      | $8837836.70   | 0.34%             |  |  |  | No            |                  1 | On Loan: No      |
| Liquidia Corp                                | Liquidia Corp                                              | CUSIP: 53635D202<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     22161 | NS      | $309589.17    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Phreesia Inc                                 | Phreesia Inc                                               | CUSIP: 71944F106<br>LEI: 5493000HHF8NU4QOCG53 | Long             | EC               | CORP              | US        |     24152 | NS      | $602833.92    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Surgery Partners Inc                         | Surgery Partners Inc                                       | CUSIP: 86881A100<br>LEI: 549300LC82HG33S19I03 | Long             | EC               | CORP              | US        |     30238 | NS      | $663724.10    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| CorVel Corp                                  | CorVel Corp                                                | CUSIP: 221006109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     12351 | NS      | $1343294.76   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Veracyte Inc                                 | Veracyte Inc                                               | CUSIP: 92337F107<br>LEI: 529900ESWZRHXOW27Z37 | Long             | EC               | CORP              | US        |     33775 | NS      | $1030137.50   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Ensign Group Inc/The                         | Ensign Group Inc/The                                       | CUSIP: 29358P101<br>LEI: 5493003K4HEEA8Q0BC72 | Long             | EC               | CORP              | US        |     25101 | NS      | $3237777.99   | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Organon & Co                                 | Organon & Co                                               | CUSIP: 68622V106<br>LEI: 549300AMCKY57OK2CO56 | Long             | EC               | CORP              | US        |    113628 | NS      | $1469210.04   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Abbott Laboratories                          | Abbott Laboratories                                        | CUSIP: 002824100<br>LEI: HQD377W2YR662HK5JX27 | Long             | EC               | CORP              | US        |    760418 | NS      | $99424653.50  | 3.87%             |  |  |  | No            |                  1 | On Loan: No      |
| Privia Health Group Inc                      | Privia Health Group Inc                                    | CUSIP: 74276R102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     42255 | NS      | $992147.40    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Vaxcyte Inc                                  | Vaxcyte Inc                                                | CUSIP: 92243G108<br>LEI: 254900M7NMHTGASX8D95 | Long             | EC               | CORP              | US        |     49152 | NS      | $1761607.68   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Humacyte Inc                                 | Humacyte Inc                                               | CUSIP: 44486Q103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     53780 | NS      | $77981.00     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Innoviva Inc                                 | Innoviva Inc                                               | CUSIP: 45781M101<br>LEI: 549300ACOX4QTBES6535 | Long             | EC               | CORP              | US        |     24364 | NS      | $455363.16    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Blueprint Medicines Corp                     | Blueprint Medicines Corp                                   | CUSIP: 09627Y109<br>LEI: 5299004CC60O9T5HVM83 | Long             | EC               | CORP              | US        |     27943 | NS      | $2500898.50   | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| GE HealthCare Technologies Inc               | GE HealthCare Technologies Inc                             | CUSIP: 36266G107<br>LEI: 549300OI9J7XOWZMUN85 | Long             | EC               | CORP              | US        |    200303 | NS      | $14087309.99  | 0.55%             |  |  |  | No            |                  1 | On Loan: No      |
| iRadimed Corp                                | iRadimed Corp                                              | CUSIP: 46266A109<br>LEI: 549300YVHWP0YJ1YW816 | Long             | EC               | CORP              | US        |      3219 | NS      | $168707.79    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| CareDx Inc                                   | CareDx Inc                                                 | CUSIP: 14167L103<br>LEI: 549300NQOFKL9NON0U06 | Long             | EC               | CORP              | US        |     23155 | NS      | $390856.40    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Bridgebio Pharma Inc                         | Bridgebio Pharma Inc                                       | CUSIP: 10806X102<br>LEI: 54930028YG89VTY2J114 | Long             | EC               | CORP              | US        |     54155 | NS      | $2077385.80   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Prothena Corp PLC                            | Prothena Corp PLC                                          | CUSIP: 000000000<br>LEI: 5299009ZXQ8NIIJ8OL30 | Long             | EC               | CORP              | IE        |     15190 | NS      | $139748.00    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvalent Inc                                 | Nuvalent Inc                                               | CUSIP: 670703107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     16012 | NS      | $1228921.00   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Envista Holdings Corp                        | Envista Holdings Corp                                      | CUSIP: 29415F104<br>LEI: 549300BX623VURJZ5269 | Long             | EC               | CORP              | US        |     76353 | NS      | $1227756.24   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Xenon Pharmaceuticals Inc                    | Xenon Pharmaceuticals Inc                                  | CUSIP: 98420N105<br>LEI: 549300XV44Q9Z1MIPQ03 | Long             | EC               | CORP              | CA        |     28609 | NS      | $1092863.80   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Aveanna Healthcare Holdings Inc              | Aveanna Healthcare Holdings Inc                            | CUSIP: 05356F105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     21094 | NS      | $97243.34     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Kymera Therapeutics Inc                      | Kymera Therapeutics Inc                                    | CUSIP: 501575104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     16911 | NS      | $579539.97    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Stoke Therapeutics Inc                       | Stoke Therapeutics Inc                                     | CUSIP: 86150R107<br>LEI: 549300RD25SS2DIJHJ67 | Long             | EC               | CORP              | US        |     14947 | NS      | $145882.72    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Dynavax Technologies Corp                    | Dynavax Technologies Corp                                  | CUSIP: 268158201<br>LEI: 549300T5URIXWDILX594 | Long             | EC               | CORP              | US        |     51373 | NS      | $603632.75    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Dexcom Inc                                   | Dexcom Inc                                                 | CUSIP: 252131107<br>LEI: 549300YSK3QDSFR5EU59 | Long             | EC               | CORP              | US        |    171242 | NS      | $12223253.96  | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcellx Inc                                  | Arcellx Inc                                                | CUSIP: 03940C100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     14356 | NS      | $932422.20    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Rapport Therapeutics Inc                     | Rapport Therapeutics Inc                                   | CUSIP: 75383L102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7218 | NS      | $82646.10     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Pfizer Inc                                   | Pfizer Inc                                                 | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |   2484515 | NS      | $60647011.15  | 2.36%             |  |  |  | No            |                  1 | On Loan: No      |
| Bio-Techne Corp                              | Bio-Techne Corp                                            | CUSIP: 09073M104<br>LEI: 54930073RLKQ51TILZ35 | Long             | EC               | CORP              | US        |     69721 | NS      | $3510452.35   | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Ardelyx Inc                                  | Ardelyx Inc                                                | CUSIP: 039697107<br>LEI: 549300F542QR4SXHCY32 | Long             | EC               | CORP              | US        |    106702 | NS      | $587394.51    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Jazz Pharmaceuticals PLC                     | Jazz Pharmaceuticals PLC                                   | CUSIP: 000000000<br>LEI: 635400GAUMJCLEZRRV50 | Long             | EC               | CORP              | IE        |     25172 | NS      | $2944117.12   | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| LENZ Therapeutics Inc                        | LENZ Therapeutics Inc                                      | CUSIP: 52635N103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5335 | NS      | $152127.53    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| TG Therapeutics Inc                          | TG Therapeutics Inc                                        | CUSIP: 88322Q108<br>LEI: 529900X21UKABN9NJ529 | Long             | EC               | CORP              | US        |     64601 | NS      | $2939991.51   | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Edgewise Therapeutics Inc                    | Edgewise Therapeutics Inc                                  | CUSIP: 28036F105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     20643 | NS      | $338545.20    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Chemed Corp                                  | Chemed Corp                                                | CUSIP: 16359R103<br>LEI: 54930020031IDJT2IM79 | Long             | EC               | CORP              | US        |      6243 | NS      | $3630366.93   | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Molina Healthcare Inc                        | Molina Healthcare Inc                                      | CUSIP: 60855R100<br>LEI: 549300NQQCEQ46YHZ591 | Long             | EC               | CORP              | US        |     25067 | NS      | $8197159.67   | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| Sarepta Therapeutics Inc                     | Sarepta Therapeutics Inc                                   | CUSIP: 803607100<br>LEI: 549300IKDPIED8J8IG21 | Long             | EC               | CORP              | US        |     37741 | NS      | $2355038.40   | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Edwards Lifesciences Corp                    | Edwards Lifesciences Corp                                  | CUSIP: 28176E108<br>LEI: YA13X31F3V31L8TMPR58 | Long             | EC               | CORP              | US        |    258578 | NS      | $19520053.22  | 0.76%             |  |  |  | No            |                  1 | On Loan: No      |
| Apogee Therapeutics Inc                      | Apogee Therapeutics Inc                                    | CUSIP: 03770N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      9813 | NS      | $385160.25    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Fulgent Genetics Inc                         | Fulgent Genetics Inc                                       | CUSIP: 359664109<br>LEI: 549300CL6P01M68QJ404 | Long             | EC               | CORP              | US        |      9602 | NS      | $166594.70    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Astria Therapeutics Inc                      | Astria Therapeutics Inc                                    | CUSIP: 04635X102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     11134 | NS      | $57451.44     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Solventum Corp                               | Solventum Corp                                             | CUSIP: 83444M101<br>LEI: 254900I70403OSGY4M28 | Long             | EC               | CORP              | US        |     64267 | NS      | $4249334.04   | 0.17%             |  |  |  | No            |                  1 | On Loan: No      |
| Progyny Inc                                  | Progyny Inc                                                | CUSIP: 74340E103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     31707 | NS      | $724187.88    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Cardinal Health Inc                          | Cardinal Health Inc                                        | CUSIP: 14149Y108<br>LEI: CCU46N3GJMF4OK4N7U60 | Long             | EC               | CORP              | US        |    106104 | NS      | $14991434.16  | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Cencora Inc                                  | Cencora Inc                                                | CUSIP: 03073E105<br>LEI: AI8GXW8LG5WK7E9UD086 | Long             | EC               | CORP              | US        |     76262 | NS      | $22319599.54  | 0.87%             |  |  |  | No            |                  1 | On Loan: No      |
| Enliven Therapeutics Inc                     | Enliven Therapeutics Inc                                   | CUSIP: 29337E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      9279 | NS      | $175744.26    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Option Care Health Inc                       | Option Care Health Inc                                     | CUSIP: 68404L201<br>LEI: 549300DI3Q5ACSYJRI17 | Long             | EC               | CORP              | US        |     74471 | NS      | $2406158.01   | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| LeMaitre Vascular Inc                        | LeMaitre Vascular Inc                                      | CUSIP: 525558201<br>LEI: 549300FZUBUB7MHY8R17 | Long             | EC               | CORP              | US        |      8958 | NS      | $812848.92    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Embecta Corp                                 | Embecta Corp                                               | CUSIP: 29082K105<br>LEI: 549300RPG8GXVDHNXZ62 | Long             | EC               | CORP              | US        |     24537 | NS      | $299106.03    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| NeoGenomics Inc                              | NeoGenomics Inc                                            | CUSIP: 64049M209<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     55697 | NS      | $356182.32    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| OMNIAB INC                                   | OMNIAB INC                                                 | CUSIP: 68218J202<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3335 | NS      | $7170.25      | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Schrodinger Inc/United States                | Schrodinger Inc/United States                              | CUSIP: 80810D103<br>LEI: 984500044BAE4791E559 | Long             | EC               | CORP              | US        |     27492 | NS      | $704619.96    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Ultragenyx Pharmaceutical Inc                | Ultragenyx Pharmaceutical Inc                              | CUSIP: 90400D108<br>LEI: 529900EV44GVDN1DCX77 | Long             | EC               | CORP              | US        |     36223 | NS      | $1411972.54   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Praxis Precision Medicines Inc               | Praxis Precision Medicines Inc                             | CUSIP: 74006W207<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5947 | NS      | $223845.08    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Owens & Minor Inc                            | Owens & Minor Inc                                          | CUSIP: 690732102<br>LEI: 549300LMT5KQQXCEZ733 | Long             | EC               | CORP              | US        |     30973 | NS      | $218669.38    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Insmed Inc                                   | Insmed Inc                                                 | CUSIP: 457669307<br>LEI: 529900Q55QAG41CCAC11 | Long             | EC               | CORP              | US        |     74459 | NS      | $5361048.00   | 0.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcus Biosciences Inc                        | Arcus Biosciences Inc                                      | CUSIP: 03969F109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     29905 | NS      | $261668.75    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Acadia Healthcare Co Inc                     | Acadia Healthcare Co Inc                                   | CUSIP: 00404A109<br>LEI: 5493005CW985Y9D0NC11 | Long             | EC               | CORP              | US        |     40530 | NS      | $948402.00    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcutis Biotherapeutics Inc                  | Arcutis Biotherapeutics Inc                                | CUSIP: 03969K108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     45504 | NS      | $678464.64    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Vir Biotechnology Inc                        | Vir Biotechnology Inc                                      | CUSIP: 92764N102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     40126 | NS      | $245571.12    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Orthofix Medical Inc                         | Orthofix Medical Inc                                       | CUSIP: 68752M108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     14513 | NS      | $201875.83    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Vericel Corp                                 | Vericel Corp                                               | CUSIP: 92346J108<br>LEI: 54930076YM3PLTDR4B91 | Long             | EC               | CORP              | US        |     21422 | NS      | $814464.44    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Harmony Biosciences Holdings Inc             | Harmony Biosciences Holdings Inc                           | CUSIP: 413197104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     18743 | NS      | $552356.21    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| RadNet Inc                                   | RadNet Inc                                                 | CUSIP: 750491102<br>LEI: 529900RECG94V2IZJ970 | Long             | EC               | CORP              | US        |     27721 | NS      | $1452025.98   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Arvinas Inc                                  | Arvinas Inc                                                | CUSIP: 04335A105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     20804 | NS      | $200134.48    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Tenet Healthcare Corp                        | Tenet Healthcare Corp                                      | CUSIP: 88033G407<br>LEI: 0W9AIBT6U6ADJ2I8HK17 | Long             | EC               | CORP              | US        |     41775 | NS      | $5971736.25   | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Azenta Inc                                   | Azenta Inc                                                 | CUSIP: 114340102<br>LEI: 35ZN6X1ANPH25YN32Y17 | Long             | EC               | CORP              | US        |     18022 | NS      | $474699.48    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Altimmune Inc                                | Altimmune Inc                                              | CUSIP: 02155H200<br>LEI: 549300EOYCQ8SW3NVE64 | Long             | EC               | CORP              | US        |     30849 | NS      | $161957.25    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Cogent Biosciences Inc                       | Cogent Biosciences Inc                                     | CUSIP: 19240Q201<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     31470 | NS      | $163958.70    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| HealthStream Inc                             | HealthStream Inc                                           | CUSIP: 42222N103<br>LEI: 529900OJ88H8635JNH64 | Long             | EC               | CORP              | US        |     10591 | NS      | $356175.33    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Natera Inc                                   | Natera Inc                                                 | CUSIP: 632307104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     54981 | NS      | $8298282.33   | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| Neurocrine Biosciences Inc                   | Neurocrine Biosciences Inc                                 | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |     44479 | NS      | $4789943.51   | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| State Street Global Advisors                 | State Street Institutional Treasury Plus Money Market Fund | CUSIP: 857492862<br>LEI: 549300PNASLVKQG64331 | Long             | STIV             | RF                | US        |   5844000 | NS      | $5844000.00   | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Exelixis Inc                                 | Exelixis Inc                                               | CUSIP: 30161Q104<br>LEI: 254900PJQB59O2O95R37 | Long             | EC               | CORP              | US        |    112797 | NS      | $4416002.55   | 0.17%             |  |  |  | No            |                  1 | On Loan: No      |
| CONTRA RADIUS HEALTH I                       | Radius Health, Inc.                                        | CUSIP: 750CVR011<br>LEI: 549300EV6I2M6E0YVT27 | Long             | EC               | CORP              | US        |     20244 | NS      | $0.20         | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| HealthEquity Inc                             | HealthEquity Inc                                           | CUSIP: 42226A107<br>LEI: 529900LRJU1RAFQHM467 | Long             | EC               | CORP              | US        |     38085 | NS      | $3264646.20   | 0.13%             |  |  |  | No            |                  1 | On Loan: No      |
| HCA Healthcare Inc                           | HCA Healthcare Inc                                         | CUSIP: 40412C101<br>LEI: 529900PH4ZGUH2MNEU89 | Long             | EC               | CORP              | US        |     83286 | NS      | $28740332.88  | 1.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Standard BioTools Inc                        | Standard BioTools Inc                                      | CUSIP: 34385P108<br>LEI: 549300GX8Y96GSB6YP89 | Long             | EC               | CORP              | US        |     95587 | NS      | $106101.57    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Crinetics Pharmaceuticals Inc                | Crinetics Pharmaceuticals Inc                              | CUSIP: 22663K107<br>LEI: 549300Q1CNFXK5P31D28 | Long             | EC               | CORP              | US        |     36569 | NS      | $1221038.91   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Masimo Corp                                  | Masimo Corp                                                | CUSIP: 574795100<br>LEI: 549300Q4A8JK0PIYCU29 | Long             | EC               | CORP              | US        |     19933 | NS      | $3208415.68   | 0.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Bio-Rad Laboratories Inc                     | Bio-Rad Laboratories Inc                                   | CUSIP: 090572207<br>LEI: 549300ZC1GPV35XYDK53 | Long             | EC               | CORP              | US        |      8558 | NS      | $2088836.64   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Avantor Inc                                  | Avantor Inc                                                | CUSIP: 05352A100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    298379 | NS      | $3875943.21   | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| McKesson Corp                                | McKesson Corp                                              | CUSIP: 58155Q103<br>LEI: 549300WZWOM80UCFSF54 | Long             | EC               | CORP              | US        |     55659 | NS      | $39673178.61  | 1.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Humana Inc                                   | Humana Inc                                                 | CUSIP: 444859102<br>LEI: 529900YLDW34GJAO4J06 | Long             | EC               | CORP              | US        |     52787 | NS      | $13842862.88  | 0.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Fortrea Holdings Inc                         | Fortrea Holdings Inc                                       | CUSIP: 34965K107<br>LEI: 5493000FIVFABOVCDU97 | Long             | EC               | CORP              | US        |     38076 | NS      | $237213.48    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Certara Inc                                  | Certara Inc                                                | CUSIP: 15687V109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     56442 | NS      | $782286.12    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| CG oncology Inc                              | CG oncology Inc                                            | CUSIP: 156944100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     17871 | NS      | $481444.74    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Lantheus Holdings Inc                        | Lantheus Holdings Inc                                      | CUSIP: 516544103<br>LEI: 5299005HUB5IOJGO7S39 | Long             | EC               | CORP              | US        |     30599 | NS      | $3192699.66   | 0.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Pulse Biosciences Inc                        | Pulse Biosciences Inc                                      | CUSIP: 74587B101<br>LEI: 529900NJUBI06118FM73 | Long             | EC               | CORP              | US        |      5389 | NS      | $91720.78     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Astrana Health Inc                           | Astrana Health Inc                                         | CUSIP: 03763A207<br>LEI: 5493008O4R82Q4STJ936 | Long             | EC               | CORP              | US        |     20051 | NS      | $624989.67    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Cytokinetics Inc                             | Cytokinetics Inc                                           | CUSIP: 23282W605<br>LEI: 549300BE5DY1HW7IHA64 | Long             | EC               | CORP              | US        |     49391 | NS      | $2115910.44   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Danaher Corp                                 | Danaher Corp                                               | CUSIP: 235851102<br>LEI: S4BKK9OTCEWQ3YHPFM11 | Long             | EC               | CORP              | US        |    284991 | NS      | $56807256.03  | 2.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Haemonetics Corp                             | Haemonetics Corp                                           | CUSIP: 405024100<br>LEI: 549300ZEL6TXZS6F5F95 | Long             | EC               | CORP              | US        |     21961 | NS      | $1383982.22   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Concentra Group Holdings Parent Inc          | Concentra Group Holdings Parent Inc                        | CUSIP: 20603L102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     50242 | NS      | $1092763.50   | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals Inc                | Regeneron Pharmaceuticals Inc                              | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |     47379 | NS      | $28368650.04  | 1.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Ocular Therapeutix Inc                       | Ocular Therapeutix Inc                                     | CUSIP: 67576A100<br>LEI: 529900ABAWFXOHSIHG03 | Long             | EC               | CORP              | US        |     40758 | NS      | $338291.40    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| ICU Medical Inc                              | ICU Medical Inc                                            | CUSIP: 44930G107<br>LEI: 5493003NRW7LS2QZRH60 | Long             | EC               | CORP              | US        |     10118 | NS      | $1382017.62   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Integer Holdings Corp                        | Integer Holdings Corp                                      | CUSIP: 45826H109<br>LEI: 549300SUD2ED5XG6X569 | Long             | EC               | CORP              | US        |     14706 | NS      | $1857514.86   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Kiniksa Pharmaceuticals International Plc    | Kiniksa Pharmaceuticals International Plc                  | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | GB        |     15968 | NS      | $430656.96    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Teleflex Inc                                 | Teleflex Inc                                               | CUSIP: 879369106<br>LEI: UUL85LWXB4NGSWWXIQ25 | Long             | EC               | CORP              | US        |     20353 | NS      | $2789378.65   | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Nurix Therapeutics Inc                       | Nurix Therapeutics Inc                                     | CUSIP: 67080M103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     26379 | NS      | $304149.87    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Enovis Corp                                  | Enovis Corp                                                | CUSIP: 194014502<br>LEI: 635400OP2DYYYMOIYL17 | Long             | EC               | CORP              | US        |     24455 | NS      | $845898.45    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Syndax Pharmaceuticals Inc                   | Syndax Pharmaceuticals Inc                                 | CUSIP: 87164F105<br>LEI: 529900OF94TRHKZVBS87 | Long             | EC               | CORP              | US        |     33244 | NS      | $470402.60    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| OPKO Health Inc                              | OPKO Health Inc                                            | CUSIP: 68375N103<br>LEI: 529900A4S2D4OGOJLL02 | Long             | EC               | CORP              | US        |    151815 | NS      | $209504.70    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Cross Country Healthcare Inc                 | Cross Country Healthcare Inc                               | CUSIP: 227483104<br>LEI: 54930037L0NBIPZ5S663 | Long             | EC               | CORP              | US        |     12019 | NS      | $162857.45    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Immunovant Inc                               | Immunovant Inc                                             | CUSIP: 45258J102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     29478 | NS      | $476069.70    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Glaukos Corp                                 | Glaukos Corp                                               | CUSIP: 377322102<br>LEI: 5299004JA1LHE21M6T14 | Long             | EC               | CORP              | US        |     24219 | NS      | $2282640.75   | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Day One Biopharmaceuticals Inc               | Day One Biopharmaceuticals Inc                             | CUSIP: 23954D109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     25318 | NS      | $196974.04    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Rocket Pharmaceuticals Inc                   | Rocket Pharmaceuticals Inc                                 | CUSIP: 77313F106<br>LEI: 549300R7VV82YUIN4Y93 | Long             | EC               | CORP              | US        |     34110 | NS      | $260259.30    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Mettler-Toledo International Inc             | Mettler-Toledo International Inc                           | CUSIP: 592688105<br>LEI: 5493000BD5GJNUDIUG10 | Long             | EC               | CORP              | US        |      9250 | NS      | $9902772.50   | 0.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Artivion Inc                                 | Artivion Inc                                               | CUSIP: 228903100<br>LEI: 549300YTKV8DMSMG6K81 | Long             | EC               | CORP              | US        |     16553 | NS      | $392140.57    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| QuidelOrtho Corp                             | QuidelOrtho Corp                                           | CUSIP: 219798105<br>LEI: 549300YU8CMO9HF53113 | Long             | EC               | CORP              | US        |     29348 | NS      | $815580.92    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Encompass Health Corp                        | Encompass Health Corp                                      | CUSIP: 29261A100<br>LEI: 549300FVRPM9DRQZRG64 | Long             | EC               | CORP              | US        |     44104 | NS      | $5159726.96   | 0.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Aurinia Pharmaceuticals Inc                  | Aurinia Pharmaceuticals Inc                                | CUSIP: 05156V102<br>LEI: 5299008YP2BW4570ML28 | Long             | EC               | CORP              | CA        |     53072 | NS      | $437313.28    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Soleno Therapeutics Inc                      | Soleno Therapeutics Inc                                    | CUSIP: 834203309<br>LEI: 5493003LCY77N7FXK844 | Long             | EC               | CORP              | US        |     11324 | NS      | $847714.64    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Savara Inc                                   | Savara Inc                                                 | CUSIP: 805111101<br>LEI: 5493002JO0WM3YMJXG33 | Long             | EC               | CORP              | US        |     43023 | NS      | $137673.60    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Phibro Animal Health Corp                    | Phibro Animal Health Corp                                  | CUSIP: 71742Q106<br>LEI: 549300U24SP4AF2JUX52 | Long             | EC               | CORP              | US        |      8948 | NS      | $166522.28    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Alkermes PLC                                 | Alkermes PLC                                               | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | IE        |     67363 | NS      | $1938033.51   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Elanco Animal Health Inc                     | Elanco Animal Health Inc                                   | CUSIP: 28414H103<br>LEI: 549300SHPNDCE059M934 | Long             | EC               | CORP              | US        |    218059 | NS      | $2067199.32   | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Amicus Therapeutics Inc                      | Amicus Therapeutics Inc                                    | CUSIP: 03152W109<br>LEI: 549300MRD1SMUTNBPQ53 | Long             | EC               | CORP              | US        |     99203 | NS      | $761879.04    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Sotera Health Co                             | Sotera Health Co                                           | CUSIP: 83601L102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     68021 | NS      | $782241.50    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Merck & Co Inc                               | Merck & Co Inc                                             | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |   1109033 | NS      | $94489611.60  | 3.67%             |  |  |  | No            |                  1 | On Loan: No      |
| PACS Group Inc                               | PACS Group Inc                                             | CUSIP: 69380Q107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     20329 | NS      | $195768.27    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| PROCEPT BioRobotics Corp                     | PROCEPT BioRobotics Corp                                   | CUSIP: 74276L105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     22520 | NS      | $1215629.60   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| 89bio Inc                                    | 89bio Inc                                                  | CUSIP: 282559103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     46328 | NS      | $371550.56    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| SIGA Technologies Inc                        | SIGA Technologies Inc                                      | CUSIP: 826917106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     19595 | NS      | $108164.40    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Quest Diagnostics Inc                        | Quest Diagnostics Inc                                      | CUSIP: 74834L100<br>LEI: 8MCWUBXQ0WE04KMXBX50 | Long             | EC               | CORP              | US        |     48932 | NS      | $8720661.04   | 0.34%             |  |  |  | No            |                  1 | On Loan: No      |
| STERIS PLC                                   | STERIS PLC                                                 | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | IE        |     43269 | NS      | $9724275.06   | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Clover Health Investments Corp               | Clover Health Investments Corp                             | CUSIP: 18914F103<br>LEI: 5493000HLYOYQU6LK133 | Long             | EC               | CORP              | US        |    171534 | NS      | $583215.60    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Scholar Rock Holding Corp                    | Scholar Rock Holding Corp                                  | CUSIP: 80706P103<br>LEI: 549300Z1FLPGL4OWJ459 | Long             | EC               | CORP              | US        |     28710 | NS      | $944846.10    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| West Pharmaceutical Services Inc             | West Pharmaceutical Services Inc                           | CUSIP: 955306105<br>LEI: 5493007NKRGM1RJQ1P16 | Long             | EC               | CORP              | US        |     31752 | NS      | $6708880.08   | 0.26%             |  |  |  | No            |                  1 | On Loan: No      |
| Varex Imaging Corp                           | Varex Imaging Corp                                         | CUSIP: 92214X106<br>LEI: 549300CWYWPVCT8E9W67 | Long             | EC               | CORP              | US        |     17526 | NS      | $145816.32    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| PTC Therapeutics Inc                         | PTC Therapeutics Inc                                       | CUSIP: 69366J200<br>LEI: 549300UJLWOIWFDGB318 | Long             | EC               | CORP              | US        |     30592 | NS      | $1524705.28   | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Capricor Therapeutics Inc                    | Capricor Therapeutics Inc                                  | CUSIP: 14070B309<br>LEI: 5493002ZI5PDLXV4DX14 | Long             | EC               | CORP              | US        |     17931 | NS      | $227723.70    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Waters Corp                                  | Waters Corp                                                | CUSIP: 941848103<br>LEI: 5T547R1474YC9HOD8Q74 | Long             | EC               | CORP              | US        |     26043 | NS      | $9055932.39   | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co                               | Eli Lilly & Co                                             | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |    353769 | NS      | $318020642.55 | 12.37%            |  |  |  | No            |                  1 | On Loan: No      |
| Novavax Inc                                  | Novavax Inc                                                | CUSIP: 670002401<br>LEI: 529900J4GJHPEPQ23205 | Long             | EC               | CORP              | US        |     62904 | NS      | $419569.68    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Henry Schein Inc                             | Henry Schein Inc                                           | CUSIP: 806407102<br>LEI: VGO3WGL8H45T73F4RR92 | Long             | EC               | CORP              | US        |     54634 | NS      | $3549570.98   | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Evolus Inc                                   | Evolus Inc                                                 | CUSIP: 30052C107<br>LEI: 549300VYQRYBQOT8V419 | Long             | EC               | CORP              | US        |     20556 | NS      | $234338.40    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| SpringWorks Therapeutics Inc                 | SpringWorks Therapeutics Inc                               | CUSIP: 85205L107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     25952 | NS      | $1201577.60   | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Royalty Pharma PLC                           | Royalty Pharma PLC                                         | CUSIP: 000000000<br>LEI: 549300FGFN7VOK8BZR03 | Long             | EC               | CORP              | GB        |    165486 | NS      | $5431250.52   | 0.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Mirum Pharmaceuticals Inc                    | Mirum Pharmaceuticals Inc                                  | CUSIP: 604749101<br>LEI: 254900YZKR40F7F27K81 | Long             | EC               | CORP              | US        |     15968 | NS      | $693809.60    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Roivant Sciences Ltd                         | Roivant Sciences Ltd                                       | CUSIP: 000000000<br>LEI: 549300DL466NY5J6U724 | Long             | EC               | CORP              | BM        |    159045 | NS      | $1848102.90   | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Castle Biosciences Inc                       | Castle Biosciences Inc                                     | CUSIP: 14843C105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     11835 | NS      | $237291.75    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Corcept Therapeutics Inc                     | Corcept Therapeutics Inc                                   | CUSIP: 218352102<br>LEI: 529900EO9LUTFMZ7FF90 | Long             | EC               | CORP              | US        |     41247 | NS      | $2964834.36   | 0.12%             |  |  |  | No            |                  1 | On Loan: No      |
| IDEXX Laboratories Inc                       | IDEXX Laboratories Inc                                     | CUSIP: 45168D104<br>LEI: OGMTXK0LUU1HKV2P0J84 | Long             | EC               | CORP              | US        |     35901 | NS      | $15532567.65  | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Annexon Inc                                  | Annexon Inc                                                | CUSIP: 03589W102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     29991 | NS      | $55783.26     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Hologic Inc                                  | Hologic Inc                                                | CUSIP: 436440101<br>LEI: 549300DYP6F5ZJL0LB74 | Long             | EC               | CORP              | US        |     99429 | NS      | $5786767.80   | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Bioventus Inc                                | Bioventus Inc                                              | CUSIP: 09075A108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     15657 | NS      | $114452.67    | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Baxter International Inc                     | Baxter International Inc                                   | CUSIP: 071813109<br>LEI: J5OIVXX3P24RJRW5CK77 | Long             | EC               | CORP              | US        |    223855 | NS      | $6977560.35   | 0.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Bristol-Myers Squibb Co                      | Bristol-Myers Squibb Co                                    | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |    889195 | NS      | $44637589.00  | 1.74%             |  |  |  | No            |                  1 | On Loan: No      |
| ARS Pharmaceuticals Inc                      | ARS Pharmaceuticals Inc                                    | CUSIP: 82835W108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     17921 | NS      | $250356.37    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Xencor Inc                                   | Xencor Inc                                                 | CUSIP: 98401F105<br>LEI: 549300V5IF65437JKG30 | Long             | EC               | CORP              | US        |     25832 | NS      | $284668.64    | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Maravai LifeSciences Holdings Inc            | Maravai LifeSciences Holdings Inc                          | CUSIP: 56600D107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     49347 | NS      | $99680.94     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Tyra Biosciences Inc                         | Tyra Biosciences Inc                                       | CUSIP: 90240B106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6640 | NS      | $68392.00     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc                          | Gilead Sciences Inc                                        | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |    546390 | NS      | $58212390.60  | 2.26%             |  |  |  | No            |                  1 | On Loan: No      |
| Janux Therapeutics Inc                       | Janux Therapeutics Inc                                     | CUSIP: 47103J105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     18517 | NS      | $614764.40    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| MannKind Corp                                | MannKind Corp                                              | CUSIP: 56400P706<br>LEI: 213800GFBCNY1ZFST722 | Long             | EC               | CORP              | US        |    118580 | NS      | $597643.20    | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-05-28

**Name of Applicant:** FIDELITY COVINGTON TRUST

**Signature:** Stacie M Smith

**Name of Signer:** Stacie M Smith

**Title:** President and Treasurer